Clinical	JJ	amod	O
,	,	punct	O
laboratory	NN	conj	O
,	,	punct	O
histopathological	JJ	conj	O
,	,	punct	O
and	CC	cc	O
pharmacological	JJ	conj	O
evidence	NN	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
notion	NN	dobj	O
that	IN	mark	O
the	DT	det	O
coagulation	NN	compound	O
system	NN	nsubj	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	acl:relcl	O
in	IN	case	O
most	JJS	amod	O
cancer	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
,	,	punct	O
plays	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
biology	NN	nmod	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
VASP	NN	nmod	B-Gene_or_gene_product
induces	VBZ	ROOT	O
marked	JJ	amod	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	dobj	O
and	CC	cc	O
formation	NN	conj	O
of	IN	case	O
prominent	JJ	amod	O
stress	NN	compound	B-Cellular_component
fibers	NNS	nmod	I-Cellular_component
in	IN	case	O
bovine	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
experimental	JJ	amod	O
facts	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
acquisition	NN	nsubj	O
of	IN	case	O
metastatic	JJ	amod	O
ability	NN	nmod	O
coupled	VBN	acl	O
with	IN	case	O
the	DT	det	O
function	NN	nmod	O
of	IN	case	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	nmod	O
was	VBD	cop	O
conditional	JJ	ccomp	O
in	IN	case	O
nature	NN	nmod	O
,	,	punct	O
being	VBG	auxpass	O
strongly	RB	advmod	O
affected	VBN	advcl	O
by	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
tumor	NN	compound	B-Cancer
circumstances	NNS	nmod	O
.	.	punct	O

Acetylation	NN	nsubjpass	O
of	IN	case	O
histone	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
non	JJ	amod	O
-	HYPH	punct	O
histone	NN	conj	B-Gene_or_gene_product
proteins	NNS	dep	O
,	,	punct	O
induction	NN	nsubjpass	O
of	IN	case	O
apoptotic	JJ	amod	O
-	HYPH	punct	O
related	JJ	amod	O
proteins	NNS	nmod	O
and	CC	cc	O
de	FW	amod	O
-	HYPH	punct	O
phosphorylation	NN	conj	O
of	IN	case	O
focal	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
were	VBD	auxpass	O
confirmed	VBN	ROOT	O
in	IN	case	O
treated	VBN	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
mechanism	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
by	IN	case	O
which	WDT	nmod	O
VEGFR2	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubjpass	O
and	CC	cc	O
trafficking	NN	conj	O
is	VBZ	auxpass	O
coordinated	VBN	acl:relcl	O
are	VBP	cop	O
not	RB	neg	O
clear	JJ	ROOT	O
.	.	punct	O

Angiogenesis	NNP	compound	O
-	HYPH	punct	O
-	HYPH	punct	O
one	CD	nsubj	O
of	IN	prep	O
the	DT	det	O
hallmarks	NNS	pobj	O
of	IN	prep	O
cancer	NN	pobj	B-Cancer
-	HYPH	punct	O
-	:	punct	O
has	VBZ	aux	O
emerged	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
valid	JJ	amod	O
therapeutic	JJ	amod	O
target	NN	nmod	O
in	IN	case	O
oncology	NN	nmod	O
.	.	punct	O

This	DT	det	O
prospective	JJ	amod	O
study	NN	ROOT	O
aimed	VBN	acl	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
efficacy	NN	dobj	O
and	CC	cc	O
individual	JJ	amod	O
benefit	NN	conj	O
of	IN	case	O
external	JJ	amod	O
beam	NN	compound	O
radiotherapy	NN	nmod	O
(	-LRB-	punct	O
EBRT	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
effect	NN	ROOT	O
of	IN	case	O
perfluorocarbon	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
based	VBN	amod	O
artificial	JJ	amod	O
oxygen	NN	compound	B-Simple_chemical
carriers	NNS	nmod	O
on	IN	case	O
tissue	NN	npadvmod	B-Multi-tissue_structure
-	HYPH	punct	I-Multi-tissue_structure
engineered	VBN	amod	I-Multi-tissue_structure
trachea	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

The	DT	det	O
selective	JJ	amod	O
antimetastatic	JJ	amod	O
agents	NNS	nsubjpass	O
p	NN	dep	B-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
3	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dimethyl	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
triazeno	NN	conj	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
benzoic	JJ	amod	I-Simple_chemical
acid	NN	compound	I-Simple_chemical
potassium	NN	compound	I-Simple_chemical
salt	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
DM	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
COOK	NN	conj	I-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
5	CD	conj	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
3	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dimethyl	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
triazeno	NN	dep	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
imidazole	NN	amod	I-Simple_chemical
-	SYM	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
carboxamide	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
DTIC	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
(	-LRB-	punct	B-Simple_chemical
+	CC	cc	I-Simple_chemical
/	SYM	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
1	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
di	NN	conj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
5	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dioxopiperazin	NN	amod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
yl	NN	dep	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
propane	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
ICRF	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
159	CD	appos	I-Simple_chemical
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
markedly	RB	advmod	O
depress	VB	xcomp	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
spontaneous	JJ	amod	O
hematogenous	JJ	amod	O
metastases	NNS	nmod	B-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
bearing	VBG	acl	O
s	NNS	dobj	O
.	.	punct	O
c	LS	ROOT	O
.	.	punct	O

Hematogenous	JJ	amod	O
metastasis	NN	nsubj	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
requires	VBZ	ROOT	O
isolated	VBN	amod	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Glucose	NN	compound	B-Simple_chemical
metabolism	NN	nsubj	O
and	CC	cc	O
amino	NN	compound	B-Amino_acid
acid	NN	compound	I-Amino_acid
uptake	NN	conj	O
of	IN	case	O
the	DT	det	O
brain	NN	compound	B-Cancer
tumours	NNS	nmod	I-Cancer
correlated	VBD	ROOT	O
significantly	RB	advmod	O
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
71	CD	nummod	O
,	,	punct	O
P	NN	compound	O
<	-LRB-	ROOT	O
0	CD	nummod	O
.	.	punct	O
001	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Each	DT	nsubj	O
was	VBD	ROOT	O
legally	RB	advmod	O
blind	JJ	acomp	O
before	IN	case	O
treatment	NN	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
1	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
experienced	VBN	conj	O
little	JJ	dobj	O
to	TO	prep	O
no	DT	neg	O
subjective	JJ	amod	O
improvement	NN	pobj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
2	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
was	VBD	cop	O
poorly	RB	advmod	O
compliant	JJ	conj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
2	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
positive	JJ	amod	O
correlation	NN	nsubjpass	O
between	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
volume	NN	nmod	O
and	CC	cc	O
bone	NN	compound	B-Tissue
volume	NN	compound	O
density	NN	conj	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
younger	JJR	amod	O
new	JJ	amod	O
-	HYPH	punct	O
bone	NN	compound	B-Tissue
area	NN	nmod	O
but	CC	cc	O
not	RB	cc	O
in	IN	conj	O
the	DT	det	O
oldest	JJS	amod	O
new	JJ	amod	O
-	HYPH	punct	O
bone	NN	compound	B-Tissue
area	NN	pobj	O
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
functional	JJ	amod	O
units	NNS	nmod	O
with	IN	case	O
these	DT	det	O
various	JJ	amod	O
proteins	NNS	nmod	O
allows	VBZ	ROOT	O
the	DT	det	O
uPAR	NN	dobj	B-Gene_or_gene_product
to	TO	mark	O
mediate	VB	xcomp	O
the	DT	det	O
focused	JJ	amod	O
proteolysis	NN	dobj	O
required	VBN	acl	O
for	IN	case	O
cell	NN	compound	B-Cell
migration	NN	nmod	O
and	CC	cc	O
invasion	NN	conj	O
and	CC	cc	O
to	TO	mark	O
contribute	VB	conj	O
both	CC	cc:preconj	O
directly	RB	advmod	O
and	CC	advmod	O
indirectly	RB	advmod	O
to	TO	case	O
cell	NN	compound	B-Cell
adhesive	JJ	amod	O
processes	NNS	nmod	O
in	IN	case	O
a	DT	det	O
non	JJ	amod	O
-	HYPH	punct	O
proteolytic	JJ	amod	O
fashion	NN	nmod	O
.	.	punct	O

VEGF	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
was	VBD	cop	O
higher	JJR	ROOT	O
in	IN	case	O
alinidine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
rats	NNS	nmod	B-Organism
than	IN	case	O
in	IN	case	O
controls	NNS	nmod	O
after	IN	case	O
2	CD	nummod	O
weeks	NNS	nmod	O
and	CC	cc	O
increased	VBN	conj	O
further	RB	advmod	O
after	IN	case	O
3	CD	nummod	O
weeks	NNS	nmod	O
of	IN	case	O
treatment	NN	nmod	O
.	.	punct	O

Specific	JJ	amod	O
miRNAs	NN	nsubjpass	O
(	-LRB-	punct	O
angiomiRs	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
have	VBP	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
regulate	VB	xcomp	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Brn	RB	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3a	NN	nsubjpass	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
POU	NN	compound	O
gene	NN	compound	O
family	NN	nmod	O
(	-LRB-	punct	O
so	RB	advmod	O
-	HYPH	punct	O
called	VBN	dep	O
because	IN	prep	O
of	IN	pcomp	O
the	DT	det	O
similarity	NN	pobj	O
with	IN	case	O
the	DT	det	O
group	NN	nmod	O
of	IN	case	O
transcription	NN	compound	O
factors	NNS	nmod	O
Pit	VBP	dep	B-Gene_or_gene_product
,	,	punct	O
Oct	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
Unc	NNP	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
neuronal	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
engaged	VBN	acl	O
in	IN	case	O
the	DT	det	O
transcription	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
p1	NN	compound	O
and	CC	cc	O
p2	NN	conj	O
promoters	NNS	nmod	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
powerful	JJ	amod	O
antiapoptotic	JJ	amod	O
gene	NN	nmod	O
,	,	punct	O
namely	RB	advmod	O
,	,	punct	O
Bcl	NN	npadvmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
deficiency	NN	nsubj	O
dramatically	RB	advmod	O
enhanced	VBD	ROOT	O
susceptibility	NN	dobj	O
to	TO	case	O
skin	NN	compound	B-Organ
carcinogenesis	NN	nmod	O
and	CC	cc	O
resulted	VBD	conj	O
in	IN	case	O
accelerated	VBN	amod	O
and	CC	cc	O
increased	VBN	conj	O
tumor	NN	compound	B-Cancer
formation	NN	nmod	O
.	.	punct	O

The	DT	det	O
vessels	NNS	nsubjpass	B-Multi-tissue_structure
are	VBP	auxpass	O
derived	VBN	ROOT	O
from	IN	case	O
quiescient	JJ	amod	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
within	IN	case	O
the	DT	det	O
fat	NN	nmod	B-Tissue
.	.	punct	O

The	DT	det	O
epithelioid	JJ	amod	B-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
entirely	RB	advmod	O
supported	VBN	ROOT	O
by	IN	case	O
proliferated	VBN	amod	O
capillaries	NNS	nmod	B-Tissue
and	CC	cc	O
arteries	NNS	conj	B-Multi-tissue_structure
together	RB	advmod	O
with	IN	case	O
collagenous	JJ	amod	B-Tissue
stroma	NN	nmod	I-Tissue
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
serum	NN	nmod:npmod	B-Organism_substance
-	HYPH	punct	O
free	JJ	amod	O
conditioned	JJ	amod	O
medium	NN	nsubj	O
from	IN	case	O
MDA	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
231	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
inhibited	VBD	ROOT	O
the	DT	det	O
NK	NN	compound	B-Cell
cell	NN	compound	I-Cell
activity	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
blood	NN	compound	B-Cell
lymphocytes	NNS	nmod	I-Cell
.	.	punct	O

Although	IN	mark	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
significant	JJ	amod	O
difference	NN	nsubj	O
of	IN	case	O
the	DT	det	O
H	NN	nmod	B-Organism
.	.	punct	I-Organism
pylori	NNS	compound	I-Organism
positivity	NN	nsubj	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
groups	NNS	nmod	O
,	,	punct	O
the	DT	det	O
rate	NN	nsubj	O
for	IN	case	O
both	DT	det	O
groups	NNS	nmod	O
was	VBD	cop	O
higher	JJR	ROOT	O
than	IN	mark	O
reported	VBN	advcl	O
in	IN	case	O
previous	JJ	amod	O
studies	NNS	nmod	O
.	.	punct	O

Breast	NN	compound	B-Tissue
tissue	NN	nsubjpass	I-Tissue
taken	VBN	acl	O
at	IN	case	O
varying	VBG	amod	O
postoperative	JJ	amod	O
times	NNS	nmod	O
(	-LRB-	punct	O
n	NN	nsubjpass	O
=	JJ	amod	O
92	CD	dep	O
)	-RRB-	punct	O
or	CC	cc	O
during	IN	case	O
surgery	NN	conj	O
(	-LRB-	punct	O
controls	NNS	dep	O
,	,	punct	O
n	NN	nsubj	O
=	JJ	amod	O
17	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
temporal	JJ	amod	O
and	CC	cc	O
spatial	JJ	conj	O
activity	NN	dobj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
9	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
tissue	NN	compound	B-Gene_or_gene_product
inhibitor	NN	conj	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
during	IN	case	O
human	JJ	amod	B-Organism
wound	NN	compound	B-Pathological_formation
healing	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
provide	VBP	appos	O
support	NN	dobj	O
for	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
2ME2	NN	nmod	B-Simple_chemical
in	IN	case	O
combination	NN	nmod	O
with	IN	case	O
paclitaxel	NN	nmod	B-Simple_chemical
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
recurrent	JJ	amod	O
or	CC	cc	O
advanced	JJ	conj	O
head	NN	nmod	B-Cancer
and	CC	cc	I-Cancer
neck	NN	conj	I-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	dep	I-Cancer
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	B-Multi-tissue_structure
network	NN	compound	I-Multi-tissue_structure
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	B-Organism
chorioallantoic	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
transplanted	VBN	amod	O
mesenchymal	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
rats	NNS	nmod	B-Organism
of	IN	case	O
different	JJ	amod	O
ages	NNS	nmod	O
on	IN	case	O
the	DT	det	O
improvement	NN	nmod	O
of	IN	case	O
heart	NN	compound	B-Organ
function	NN	nmod	O
after	IN	case	O
acute	JJ	amod	O
myocardial	JJ	amod	B-Multi-tissue_structure
infarction	NN	nmod	O
.	.	punct	O

Serum	NN	compound	B-Organism_substance
soluble	JJ	amod	O
vascular	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
protein	NN	nsubj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
valuable	JJ	amod	O
prognostic	JJ	amod	O
marker	NN	ROOT	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

ELISA	NN	nsubj	O
found	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factors	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
both	CC	cc:preconj	O
in	IN	case	O
the	DT	det	O
tested	VBN	amod	O
oral	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
NOK	NN	conj	B-Cell
.	.	punct	O

The	DT	det	O
functional	JJ	amod	O
benefit	NN	nsubjpass	O
of	IN	case	O
cell	NN	compound	B-Cell
transplantation	NN	nmod	O
after	IN	case	O
a	DT	det	O
myocardial	JJ	amod	B-Multi-tissue_structure
infarction	NN	nmod	O
is	VBZ	auxpass	O
diminished	VBN	ROOT	O
by	IN	case	O
early	JJ	amod	O
cell	NN	compound	B-Cell
losses	NNS	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Neuroblastoma	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
grown	VBN	acl	O
in	IN	case	O
coculture	NN	compound	O
conditioned	JJ	amod	O
media	NNS	nmod	O
show	VBP	appos	O
increased	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
Bcl	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
decreased	VBN	amod	O
Fas	NN	compound	B-Gene_or_gene_product
ligand	NN	compound	I-Gene_or_gene_product
levels	NNS	dobj	O
.	.	punct	O

To	TO	mark	O
identify	VB	advcl	O
a	DT	det	O
suitable	JJ	amod	O
donor	NN	compound	B-Cell
cell	NN	compound	I-Cell
population	NN	dobj	I-Cell
for	IN	case	O
gene	NN	compound	O
therapy	NN	compound	O
applications	NNS	nmod	O
to	TO	case	O
the	DT	det	O
central	JJ	amod	B-Anatomical_system
nervous	JJ	amod	I-Anatomical_system
system	NN	nmod	I-Anatomical_system
,	,	punct	O
primary	JJ	amod	O
fibroblasts	NNS	nsubjpass	B-Cell
isolated	VBN	acl	O
from	IN	case	O
skin	NN	compound	B-Multi-tissue_structure
biopsies	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
maintained	VBN	conj	O
in	IN	case	O
culture	NN	nmod	B-Cell
are	VBP	auxpass	O
employed	VBN	ROOT	O
as	IN	case	O
autologous	JJ	amod	O
cells	NNS	nmod	B-Cell
for	IN	case	O
intracerebral	JJ	amod	B-Immaterial_anatomical_entity
grafting	VBG	nmod	O
within	IN	case	O
the	DT	det	O
adult	JJ	amod	O
rat	NN	compound	B-Organism
striatum	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

The	DT	det	O
other	JJ	amod	O
induced	VBN	amod	O
genes	NNS	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
whole	JJ	amod	O
set	NN	dobj	O
of	IN	case	O
biologically	RB	advmod	O
meaningful	JJ	amod	O
genes	NNS	nmod	O
related	JJ	amod	O
to	TO	case	O
macrophage	NN	compound	B-Cell
activation	NN	nmod	O
and	CC	cc	O
TH1	NN	compound	B-Gene_or_gene_product
immune	JJ	amod	O
response	NN	conj	O
.	.	punct	O

Both	DT	det	O
groups	NNS	nsubj	O
received	VBD	ROOT	O
either	CC	cc:preconj	O
0	CD	dobj	O
.	.	punct	O
5	CD	nummod	O
mg	NN	nummod	O
/	:	punct	O
ml	NN	compound	O
linomide	NN	nsubjpass	B-Simple_chemical
in	IN	prep	O
drinking	VBG	pcomp	O
water	NN	dobj	O
or	CC	cc	O
acidified	VBD	amod	O
water	NN	conj	O
and	CC	cc	O
were	VBD	auxpass	O
followed	VBN	ROOT	O
until	IN	case	O
tumor	NN	compound	B-Cancer
diameter	NN	nsubj	O
reached	VBD	ccomp	O
3	CD	nummod	O
cm	NN	dobj	O
or	CC	cc	O
for	IN	case	O
4	CD	nummod	O
weeks	NNS	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
at	IN	case	O
least	JJS	mwe	O
some	DT	nsubjpass	O
of	IN	case	O
these	DT	det	O
sites	NNS	nmod	O
were	VBD	auxpass	O
not	RB	neg	O
methylated	VBN	ROOT	O
in	IN	case	O
DNA	NN	nmod	B-Cellular_component
from	IN	case	O
the	DT	det	O
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cells	NNS	nmod	I-Cell
expressing	VBG	acl	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
.	.	punct	O

By	IN	prep	O
21	CD	nummod	O
days	NNS	compound	O
post	JJ	compound	O
-	HYPH	punct	O
injury	NN	pobj	O
,	,	punct	O
all	DT	det	O
activity	NN	nsubj	O
had	VBD	aux	O
returned	VBN	ROOT	O
to	TO	case	O
near	IN	case	O
baseline	NN	compound	O
level	NN	nmod	O
.	.	punct	O

In	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
biomarkers	VBZ	nsubjpass	O
that	WDT	nsubj	O
specifically	RB	advmod	O
correlate	VBP	acl:relcl	O
with	IN	case	O
the	DT	det	O
invasive	JJ	amod	O
phenotypes	NNS	nmod	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
clearly	RB	advmod	O
identified	VBN	ROOT	O
.	.	punct	O

Patients	NNS	poss	B-Organism
'	POS	case	O
reading	VBG	compound	O
vision	NN	nsubjpass	O
could	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
saved	VBN	ROOT	O
for	IN	prep	O
a	DT	det	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
run	NN	pobj	O
.	.	punct	O

VEGF165	NN	nsubj	B-Gene_or_gene_product
expressed	VBN	acl	O
by	IN	case	O
a	DT	det	O
replication	NN	nmod:npmod	O
-	HYPH	punct	O
deficient	JJ	amod	O
recombinant	JJ	amod	O
adenovirus	NN	compound	B-Organism
vector	NN	nmod	O
induces	VBZ	ROOT	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
suppression	NN	nsubj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
activation	NN	nmod	O
decreased	VBD	ROOT	O
the	DT	det	O
transcript	NN	compound	O
levels	NNS	dobj	O
and	CC	cc	O
BMP	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
phosphorylation	NN	conj	O
of	IN	case	O
Smad1	NN	nmod	B-Gene_or_gene_product
/	SYM	punct	O
5	CD	conj	B-Gene_or_gene_product
/	SYM	punct	O
8	CD	nummod	B-Gene_or_gene_product
,	,	punct	O
critical	JJ	amod	O
downstream	JJ	amod	O
targets	NNS	conj	O
of	IN	case	O
BMP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
signaling	NN	nmod	O
in	IN	case	O
PC	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Under	IN	prep	O
this	DT	det	O
condition	NN	pobj	O
,	,	punct	O
the	DT	det	O
secondary	JJ	amod	O
functions	NNS	nsubj	O
of	IN	case	O
effected	JJ	amod	O
cells	NNS	nmod	B-Cell
are	VBP	cop	O
likely	JJ	ROOT	O
to	TO	mark	O
be	VB	cop	O
impaired	JJ	xcomp	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
new	JJ	amod	O
metabolic	JJ	amod	O
equilibrium	NN	nsubjpass	O
is	VBZ	auxpass	O
established	VBN	conj	O
,	,	punct	O
determined	VBN	conj	O
by	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
cross	NN	compound	O
-	HYPH	punct	O
diffusion	NN	nmod	O
and	CC	cc	O
degree	NN	conj	O
of	IN	case	O
hypoxia	NN	nmod	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
SREBP	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
Cdc42	NN	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
Western	NN	compound	O
blot	NN	nmod	O
and	CC	cc	O
quantitative	JJ	amod	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
PCR	NN	conj	O
.	.	punct	O

Bmi	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
over	IN	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
therefore	RB	advmod	O
has	VBZ	ROOT	O
more	RBR	advmod	O
pronounced	JJ	amod	O
effects	NNS	dobj	O
in	IN	case	O
culture	NN	nmod	O
and	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
appear	VB	conj	O
to	TO	mark	O
be	VB	cop	O
sufficient	JJ	xcomp	O
to	TO	mark	O
induce	VB	xcomp	O
tumorigenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
a	DT	det	O
mutant	NN	nsubj	O
with	IN	case	O
an	DT	det	O
LMP1	NN	compound	B-Gene_or_gene_product
site	NN	compound	O
-	:	punct	O
specific	JJ	amod	O
mutation	NN	nmod	O
at	IN	case	O
TES2	NN	nmod	O
,	,	punct	O
LMP1	NN	appos	B-Gene_or_gene_product
(	-LRB-	punct	O
TRADD	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
initially	RB	advmod	O
stimulates	VBZ	ccomp	O
cell	NN	compound	B-Cell
growth	NN	dobj	O
and	CC	cc	O
significantly	RB	advmod	O
extends	VBZ	conj	O
the	DT	det	O
life	NN	compound	O
span	NN	dobj	O
of	IN	case	O
MEF	NNP	nmod	B-Cell
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
in	IN	case	O
mice	NNS	nmod	B-Organism
pleiotropic	JJ	amod	O
involvement	NN	dobj	O
of	IN	case	O
PTHrP	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
key	JJ	amod	O
steps	NNS	nmod	O
of	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
-	:	punct	O
it	PRP	nsubj	O
influences	VBZ	parataxis	O
the	DT	det	O
initiation	NN	dobj	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
primary	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
and	CC	cc	O
metastases	NNS	conj	O
.	.	punct	O

Hypoxia	NN	nsubj	O
rapidly	RB	advmod	O
induced	VBD	ROOT	O
both	CC	cc:preconj	O
JNK1	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
p38	NN	conj	B-Gene_or_gene_product
activity	NN	dobj	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
these	DT	det	O
T	NN	compound	B-Cell
-	:	punct	I-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
azacytidine	NN	nmod	I-Simple_chemical
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
DR	NN	compound	B-Gene_or_gene_product
surface	NN	compound	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
,	,	punct	O
the	DT	det	O
appearance	NN	dobj	O
of	IN	case	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
partial	JJ	amod	O
demethylation	NN	conj	O
of	IN	case	O
the	DT	det	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
DNA	NN	compound	B-Cellular_component
sequences	NNS	nmod	O
.	.	punct	O

Fibroblasts	NNS	nsubj	B-Cell
of	IN	case	O
the	DT	det	O
host	NN	compound	O
animal	NN	nmod	B-Organism
may	MD	aux	O
thus	RB	advmod	O
have	VB	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
generating	VBG	advcl	O
enhanced	VBN	amod	O
metastatic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
H	NN	compound	B-Cell
-	HYPH	punct	I-Cell
3	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

p53	NN	compound	B-Gene_or_gene_product
targets	NNS	nsubj	O
involved	VBN	acl	O
in	IN	case	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cycle	NN	compound	O
arrest	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
showed	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
mode	NN	dobj	O
of	IN	case	O
regulation	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
both	DT	nsubjpass	O
are	VBP	auxpass	O
activated	VBN	ccomp	O
simultaneously	RB	advmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
group	NN	nsubj	O
seeks	VBZ	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
basic	JJ	amod	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
ES	NN	compound	O
wound	NN	compound	B-Pathological_formation
therapy	NN	dobj	O
,	,	punct	O
an	DT	det	O
area	NN	appos	O
where	WRB	advmod	O
understanding	NN	nsubjpass	O
is	VBZ	auxpass	O
currently	RB	advmod	O
limited	JJ	acl:relcl	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
study	NN	nsubj	O
provides	VBZ	appos	O
new	JJ	amod	O
candidate	NN	compound	O
genes	NNS	dobj	O
for	IN	case	O
the	DT	det	O
esophageal	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
microenvironment	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
believed	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
the	DT	det	O
E1B	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
55kDa	JJ	amod	O
protein	NN	nmod	O
in	IN	case	O
transformation	NN	nmod	O
is	VBZ	ccomp	O
to	TO	mark	O
protect	VB	xcomp	O
against	IN	case	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	dep	O
and	CC	cc	O
inactivating	VBG	conj	O
p53	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

Immunostaining	NN	nsubj	O
and	CC	cc	O
Western	NN	compound	O
blot	NN	conj	O
revealed	VBD	ROOT	O
a	DT	det	O
more	RBR	advmod	O
significant	JJ	amod	O
PTEN	NN	compound	B-Gene_or_gene_product
downregulation	NN	dobj	O
in	IN	case	O
PTEN	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
methylated	VBN	amod	O
CCMs	NNS	nmod	B-Pathological_formation
in	IN	case	O
comparison	NN	nmod	O
to	TO	case	O
PTEN	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
unmethylated	JJ	amod	O
CCMs	NNS	nmod	B-Pathological_formation
.	.	punct	O

In	IN	case	O
pre	JJ	compound	B-Cancer
-	HYPH	punct	I-Cancer
B	NNP	compound	I-Cancer
acute	JJ	amod	I-Cancer
lymphoblastic	JJ	amod	I-Cancer
leukemia	NN	compound	I-Cancer
(	-LRB-	punct	O
ALL	NN	appos	B-Cancer
)	-RRB-	punct	O
with	IN	case	O
t	NN	nmod	O
(	-LRB-	punct	O
1	CD	nummod	O
;	:	punct	O
19	CD	dep	O
)	-RRB-	punct	O
translocation	NN	nmod	O
,	,	punct	O
a	DT	det	O
fusion	NN	compound	O
protein	NN	nsubjpass	O
is	VBZ	auxpass	O
created	VBN	ROOT	O
between	IN	case	O
E2A	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
a	DT	det	O
homeobox	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
PBX	NN	conj	B-Gene_or_gene_product
.	.	punct	O

During	IN	case	O
these	DT	det	O
processes	NNS	nmod	O
,	,	punct	O
proteolytic	JJ	amod	O
activities	NNS	nsubj	O
of	IN	case	O
tumor	NN	nmod	B-Cell
and	CC	cc	O
stromal	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
modify	VBP	ROOT	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	dobj	I-Cellular_component
to	TO	mark	O
produce	VB	xcomp	O
a	DT	det	O
microenvironment	NN	amod	O
suitable	JJ	dobj	O
for	IN	case	O
their	PRP$	poss	O
growth	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
review	NN	nmod	O
we	PRP	nsubj	O
will	MD	aux	O
discuss	VB	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
action	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
preclinical	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
results	NNS	conj	O
,	,	punct	O
of	IN	case	O
one	CD	nmod	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
promising	JJ	amod	O
antitubulin	NN	compound	B-Simple_chemical
agents	NNS	nmod	I-Simple_chemical
:	:	punct	O
the	DT	det	O
combretastatin	NN	compound	B-Simple_chemical
A4	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phosphate	NN	compound	I-Simple_chemical
derivative	NN	dep	I-Simple_chemical
,	,	punct	O
AVE8062A	NN	appos	B-Simple_chemical
.	.	punct	O

Villani	NNP	ROOT	O
et	FW	dep	O
al	FW	conj	O
.	.	punct	O
define	VB	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
the	DT	det	O
IGF	NN	compound	B-Gene_or_gene_product
regulatory	JJ	amod	O
protein	NN	compound	O
Igfbp2	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
a	DT	det	O
genetic	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
basal	JJ	amod	B-Cell
cell	NN	compound	I-Cell
carcinogenesis	NN	nmod	O
driven	VBN	acl	O
by	IN	case	O
targeted	VBN	amod	O
constitutive	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
hedgehog	JJ	amod	B-Gene_or_gene_product
signaling	NN	nmod	O
.	.	punct	O

The	DT	det	O
interaction	NN	nsubj	O
between	IN	case	O
the	DT	det	O
vascular	JJ	amod	B-Tissue
endothelium	NN	nmod	I-Tissue
and	CC	cc	O
hemodynamic	JJ	amod	O
forces	NNS	conj	O
(	-LRB-	punct	O
and	CC	cc	O
more	RBR	advmod	O
specifically	RB	advmod	O
,	,	punct	O
fluid	NN	compound	O
shear	NN	compound	O
stress	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
flow	NN	nmod	O
of	IN	case	O
blood	NN	nmod	B-Organism_substance
,	,	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
major	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
remodeling	NN	nmod	O
and	CC	cc	O
in	IN	case	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	compound	I-Multi-tissue_structure
formation	NN	conj	O
via	IN	case	O
a	DT	det	O
process	NN	nmod	O
termed	VBN	acl	O
arteriogenesis	NN	xcomp	O
.	.	punct	O

Highly	RB	advmod	O
sensitive	JJ	amod	O
reverse	NN	compound	O
-	HYPH	punct	O
transcription	NN	compound	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nsubj	O
identifies	VBZ	ROOT	O
an	DT	det	O
induction	NN	dobj	O
and	CC	cc	O
overexpression	NN	conj	O
of	IN	case	O
a	DT	det	O
type	NN	nmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
tumor	NN	compound	I-Gene_or_gene_product
HK	NN	compound	I-Gene_or_gene_product
RNA	NN	nmod	O
in	IN	case	O
a	DT	det	O
range	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
irrespective	JJ	amod	O
of	IN	case	O
tissue	NN	compound	B-Tissue
origin	NN	nmod	O
.	.	punct	O

Angiostatin	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
thalidomide	NN	conj	B-Simple_chemical
both	CC	conj	O
inhibited	VBD	ROOT	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
by	IN	prep	O
about	RB	advmod	O
55	CD	nummod	O
%	NN	pobj	O
.	.	punct	O

Isotype	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
inhibitors	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
glycolytic	JJ	amod	O
key	JJ	amod	O
regulator	NN	compound	O
pyruvate	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
subtype	NN	compound	I-Gene_or_gene_product
M2	NN	nmod	I-Gene_or_gene_product
moderately	RB	advmod	O
decelerate	VBP	ROOT	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
.	.	punct	O

Activation	NN	nsubjpass	O
of	IN	case	O
Notch	NN	compound	B-Gene_or_gene_product
proto	NN	compound	O
-	HYPH	punct	O
oncogenes	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
tumorigenesis	NN	nmod	O
in	IN	case	O
several	JJ	amod	O
human	JJ	nmod	B-Organism
and	CC	cc	O
other	JJ	amod	O
mammalian	JJ	amod	B-Cancer
cancers	NNS	conj	I-Cancer
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
two	CD	nummod	O
inflammatory	JJ	amod	O
agents	NNS	dobj	O
,	,	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1beta	NN	appos	I-Gene_or_gene_product
and	CC	cc	O
phorbol	NN	compound	B-Simple_chemical
myristic	JJ	amod	I-Simple_chemical
acetate	NN	conj	I-Simple_chemical
,	,	punct	O
to	TO	mark	O
activate	VB	advcl	O
PKC	NN	compound	B-Gene_or_gene_product
isozymes	NNS	dobj	O
and	CC	cc	O
specific	JJ	amod	O
inhibitors	NNS	conj	O
of	IN	case	O
PKCalpha	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
Go6976	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
PKCbeta	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
hispidin	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
to	TO	mark	O
distinguish	VB	advcl	O
how	WRB	advmod	O
each	DT	nsubj	O
of	IN	case	O
these	DT	det	O
isoform	NN	compound	O
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
controls	VBZ	ccomp	O
angiogenesis	NN	dobj	O
,	,	punct	O
wound	NN	compound	B-Pathological_formation
healing	NN	conj	O
,	,	punct	O
and	CC	cc	O
permeability	NN	conj	O
.	.	punct	O

The	DT	det	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
receptor	NN	ROOT	I-Gene_or_gene_product
in	IN	case	O
chronic	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukemia	NN	nmod	I-Cancer
:	:	punct	O
analysis	NN	dep	O
of	IN	case	O
microsatellite	NN	compound	O
regions	NNS	nmod	O
and	CC	cc	O
gene	NN	compound	O
expression	NN	conj	O
.	.	punct	O

DNA	NN	compound	B-Cellular_component
microarray	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
treated	VBN	amod	O
tumor	NN	nmod	B-Cancer
xenografts	NNS	advmod	I-Cancer
revealed	VBD	ROOT	O
significantly	RB	advmod	O
decreased	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	O
regulating	VBG	acl	O
glucose	NN	dobj	B-Simple_chemical
and	CC	cc	O
thymidine	NN	compound	B-Simple_chemical
metabolism	NN	conj	O
and	CC	cc	O
revealed	VBD	conj	O
changes	NNS	dobj	O
in	IN	case	O
apoptotic	JJ	amod	O
genes	NNS	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
imaging	VBG	amod	O
tracers	NNS	compound	O
FDG	NN	nsubj	B-Simple_chemical
,	,	punct	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
3	CD	conj	I-Simple_chemical
-	SYM	punct	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
18	CD	nummod	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
F	NNP	compound	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
fluorothymidine	NN	conj	I-Simple_chemical
,	,	punct	O
and	CC	cc	O
annexin	NN	compound	B-Gene_or_gene_product
V	NN	conj	I-Gene_or_gene_product
could	MD	aux	O
serve	VB	ccomp	O
as	IN	case	O
potential	JJ	amod	O
imaging	NN	amod	O
biomarkers	NNS	nmod	O
for	IN	case	O
RAF265	NN	compound	B-Simple_chemical
therapy	NN	compound	O
monitoring	NN	nmod	O
.	.	punct	O

No	DT	neg	O
effective	JJ	amod	O
medical	JJ	amod	O
therapies	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
developed	VBN	ROOT	O
sofar	RB	advmod	O
to	TO	mark	O
enhance	VB	xcomp	O
blood	NN	compound	B-Organism_substance
flow	NN	dobj	O
in	IN	case	O
the	DT	det	O
legs	NNS	nmod	B-Organism_subdivision
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
peripheral	JJ	amod	B-Multi-tissue_structure
arterial	JJ	amod	I-Multi-tissue_structure
disease	NN	nmod	O
(	-LRB-	punct	O
PAD	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Although	IN	mark	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
well	RB	advmod	O
known	VBN	advcl	O
that	IN	mark	O
Wnt	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubjpass	O
is	VBZ	auxpass	O
frequently	RB	advmod	O
dysregulated	VBN	ccomp	O
in	IN	case	O
melanoma	NN	nmod	B-Cancer
,	,	punct	O
the	DT	det	O
functional	JJ	amod	O
implications	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
observation	NN	nmod	O
are	VBP	cop	O
unclear	JJ	ROOT	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
LMP1	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ROOT	O
pleiotropic	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
cell	NN	compound	B-Cell
growth	NN	compound	O
arrest	NN	nmod	O
,	,	punct	O
differentiation	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
,	,	punct	O
depending	VBG	case	O
on	IN	case	O
the	DT	det	O
background	NN	advcl	O
of	IN	case	O
the	DT	det	O
target	NN	compound	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Calculations	NNS	nsubj	O
of	IN	prep	O
the	DT	det	O
sources	NNS	pobj	O
of	IN	case	O
energy	NN	nmod	O
for	IN	case	O
adenosine	NN	compound	B-Simple_chemical
triphosphate	NN	compound	I-Simple_chemical
synthesis	NN	nmod	O
indicated	VBD	ROOT	O
that	IN	mark	O
on	IN	case	O
the	DT	det	O
average	NN	nmod	O
about	IN	case	O
one	CD	nummod	O
-	HYPH	punct	O
third	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
respiratory	JJ	amod	O
adenosine	NN	compound	B-Simple_chemical
triphosphate	NN	nmod	I-Simple_chemical
is	VBZ	auxpass	O
generated	VBN	ccomp	O
by	IN	case	O
electron	NN	compound	B-Simple_chemical
flow	NN	compound	O
originating	VBG	nmod	O
from	IN	case	O
cytosolic	JJ	amod	B-Cellular_component
NADH	NN	nmod	B-Simple_chemical
via	IN	case	O
the	DT	det	O
malate	JJ	npadvmod	B-Simple_chemical
-	HYPH	punct	O
aspartate	NN	compound	B-Simple_chemical
shuttle	NN	nmod	O
.	.	punct	O

In	IN	case	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
transform	VBP	acl:relcl	O
to	TO	mark	O
overt	VB	xcomp	O
MDS	NN	dobj	O
or	CC	cc	O
AML	NN	conj	B-Cancer
,	,	punct	O
hematopoietic	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cell	NN	compound	I-Cell
transplantation	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
only	JJ	amod	O
chance	NN	ROOT	O
for	IN	prep	O
cure	NN	pobj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
support	VBP	ROOT	O
a	DT	det	O
new	JJ	amod	O
model	NN	dobj	O
for	IN	mark	O
how	WRB	advmod	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
trigger	VBP	acl	O
metastasis	NN	dobj	O
by	IN	mark	O
perturbing	VBG	advcl	O
pericyte	NN	compound	B-Cell
-	HYPH	punct	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
interactions	NNS	dobj	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
considerable	JJ	amod	O
debate	NN	attr	O
concerning	VBG	acl	O
where	WRB	pcomp	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
Notch	NN	compound	B-Gene_or_gene_product
functions	NNS	nmod	O
and	CC	cc	O
what	WP	dobj	O
proteins	NNS	nsubj	O
serve	VBP	conj	O
as	IN	prep	O
effectors	NNS	pobj	O
of	IN	case	O
the	DT	det	O
Notch	NN	compound	B-Gene_or_gene_product
signal	NN	nmod	O
.	.	punct	O

Long	JJ	compound	O
-	HYPH	punct	O
term	NN	compound	O
peritoneal	NN	compound	B-Multi-tissue_structure
dialysis	NN	nsubjpass	O
(	-LRB-	punct	O
PD	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
alterations	NNS	nmod	O
in	IN	case	O
peritoneal	JJ	amod	B-Multi-tissue_structure
permeability	NN	nmod	O
and	CC	cc	O
loss	NN	conj	O
of	IN	prep	O
ultrafiltration	NN	pobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
pellets	NNS	nsubj	O
from	IN	case	O
the	DT	det	O
CLA	NNP	npadvmod	B-Simple_chemical
-	HYPH	punct	O
fed	JJ	amod	O
animals	NNS	nmod	O
contained	VBD	advcl	O
fewer	JJR	amod	O
infiltrating	JJ	amod	O
cells	NNS	dobj	B-Cell
,	,	punct	O
which	WDT	nsubj	O
formed	VBD	acl:relcl	O
limited	JJ	amod	O
branching	VBG	amod	O
cellular	JJ	amod	B-Multi-tissue_structure
networks	NNS	dobj	I-Multi-tissue_structure
,	,	punct	O
the	DT	det	O
majority	NN	nsubj	O
of	IN	prep	O
which	WDT	pobj	O
had	VBD	aux	O
collapsed	VBN	ROOT	O
lumen	NN	dobj	B-Immaterial_anatomical_entity
and	CC	cc	O
no	DT	neg	O
RBCs	NNS	conj	B-Cell
.	.	punct	O

Aquaporins	NNS	ROOT	B-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
:	:	punct	O
identification	NN	dep	O
and	CC	cc	O
involvement	NN	conj	O
in	IN	case	O
carcinogenesis	NN	nmod	O
of	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

To	TO	mark	O
elucidate	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
N	NN	compound	O
-	HYPH	punct	O
glycosylation	NN	nmod	O
in	IN	case	O
the	DT	det	O
functional	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
universal	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
transporter	NN	nmod	O
,	,	punct	O
Glut	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
effects	NNS	dobj	O
of	IN	case	O
the	DT	det	O
N	NN	compound	O
-	HYPH	punct	O
glycosylation	NN	compound	O
inhibitor	NN	nmod	O
,	,	punct	O
tunicamycin	NN	appos	B-Simple_chemical
,	,	punct	O
on	IN	case	O
glucose	NN	compound	B-Simple_chemical
transport	NN	nmod	O
by	IN	case	O
human	JJ	amod	B-Organism
leukemic	JJ	amod	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
K562	NN	dep	I-Cell
,	,	punct	O
U937	NN	conj	B-Cell
and	CC	cc	O
HL60	NN	conj	B-Cell
.	.	punct	O

Experiments	NNS	nsubj	O
with	IN	prep	O
nu	CC	advmod	B-Organism
/	SYM	punct	I-Organism
nu	PRP	amod	I-Organism
mice	NNS	conj	I-Organism
,	,	punct	O
nonobese	JJ	amod	B-Organism
diabetic	JJ	amod	I-Organism
-	HYPH	punct	I-Organism
SCID	NN	compound	I-Organism
mice	NNS	conj	I-Organism
,	,	punct	O
or	CC	cc	O
activated	VBN	ROOT	O
spc	NN	advmod	B-Cell
enriched	VBN	dobj	O
in	IN	case	O
specific	JJ	amod	O
cell	NN	compound	B-Cell
subpopulations	NNS	nmod	O
demonstrated	VBD	conj	O
that	IN	mark	O
CD4	NN	nsubjpass	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
,	,	punct	O
CD8	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
NK	NN	compound	B-Cell
cells	NNS	conj	I-Cell
are	VBP	auxpass	O
all	DT	advmod	O
needed	VBN	ccomp	O
to	TO	mark	O
mediate	VB	xcomp	O
the	DT	det	O
full	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenetic	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
IL	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
only	JJ	amod	O
CD8	NN	nsubj	B-Gene_or_gene_product
+	CC	cc	O
CD56	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
postthymic	JJ	amod	O
T	NN	compound	O
-	HYPH	punct	O
cell	NN	compound	O
lymphoma	NN	conj	O
also	RB	advmod	O
expressed	VBD	ROOT	O
all	DT	det	O
three	CD	nummod	O
cytolytic	JJ	amod	O
markers	NNS	dobj	O
,	,	punct	O
two	CD	nummod	O
CD8	NN	compound	B-Gene_or_gene_product
-	:	punct	O
ALCL	NN	nsubj	O
expressed	VBD	parataxis	O
TIA1	NN	dobj	B-Gene_or_gene_product
;	:	punct	O
other	JJ	amod	O
postthymic	JJ	amod	B-Cancer
T	NN	compound	I-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
,	,	punct	O
T	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
lymphoblastic	JJ	conj	I-Cancer
,	,	punct	O
and	CC	cc	O
B	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	nsubj	I-Cancer
were	VBD	cop	O
consistently	RB	advmod	O
negative	JJ	parataxis	O
.	.	punct	O

Angiogenin	NN	ROOT	B-Gene_or_gene_product
,	,	punct	O
a	DT	quantmod	O
14	CD	appos	O
.	.	punct	O
2	CD	nummod	O
kD	NN	compound	O
polypeptide	NN	nsubjpass	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
originally	RB	advmod	O
noted	VBN	acl:relcl	O
for	IN	case	O
its	PRP$	nmod:poss	O
angiogenic	JJ	amod	O
activity	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
now	RB	advmod	O
increasingly	RB	advmod	O
recognized	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
a	DT	det	O
multiplicity	NN	dobj	O
of	IN	case	O
biological	JJ	amod	O
roles	NNS	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
physiological	JJ	amod	O
and	CC	cc	O
pathological	JJ	conj	O
conditions	NNS	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
expressed	VBN	ROOT	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
and	CC	cc	O
mutant	JJ	amod	O
forms	NNS	dobj	O
of	IN	case	O
VASP	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
to	TO	mark	O
determine	VB	xcomp	O
in	IN	mark	O
what	WDT	det	O
aspects	NNS	nsubj	O
of	IN	prep	O
cytoskeletal	JJ	amod	B-Cellular_component
behavior	NN	pobj	O
this	DT	det	O
protein	NN	nsubj	O
participates	VBZ	advcl	O
.	.	punct	O

Role	NN	nsubj	O
of	IN	case	O
stromal	JJ	amod	B-Cell
myofibroblasts	NNS	nmod	I-Cell
in	IN	case	O
invasive	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
:	:	punct	O
stromal	JJ	amod	B-Cell
expression	NN	nsubj	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
smooth	JJ	amod	I-Gene_or_gene_product
muscle	NN	compound	I-Gene_or_gene_product
actin	NN	nmod	I-Gene_or_gene_product
correlates	VBZ	ROOT	O
with	IN	case	O
worse	JJR	amod	O
clinical	JJ	amod	O
outcome	NN	nmod	O
.	.	punct	O

A	DT	det	O
feasibility	NN	compound	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
carried	VBN	ROOT	O
out	RP	prt	O
to	TO	mark	O
develop	VB	xcomp	O
the	DT	det	O
Ahn	NNP	compound	O
/	:	punct	O
Mustoe	NNP	compound	O
lapine	NN	nsubj	B-Organism
wound	NN	conj	B-Pathological_formation
model	NN	dobj	O
for	IN	case	O
systematic	JJ	amod	O
investigation	NN	nmod	O
of	IN	case	O
the	DT	det	O
effects	NNS	nmod	O
of	IN	case	O
electrical	JJ	amod	O
stimulation	NN	nmod	O
on	IN	case	O
ischemic	JJ	amod	O
wound	NN	compound	B-Pathological_formation
therapy	NN	nmod	O
.	.	punct	O

Vasodilator	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
stimulated	VBN	amod	I-Gene_or_gene_product
phosphoprotein	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
VASP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
highly	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
vascular	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
where	WRB	advmod	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	acl:relcl	O
in	IN	case	O
cellular	JJ	amod	B-Cell
reorganization	NN	nmod	O
during	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
retraction	NN	conj	O
and	CC	cc	O
changes	NNS	conj	O
in	IN	case	O
vessel	NN	compound	B-Multi-tissue_structure
permeability	NN	nmod	O
.	.	punct	O

The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
neu	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
differential	JJ	amod	O
expression	NN	conj	O
between	IN	case	O
P185neu	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
LAR	NN	compound	B-Gene_or_gene_product
/	:	punct	O
PTP1B	NN	conj	B-Gene_or_gene_product
,	,	punct	O
directly	RB	advmod	O
correlated	VBD	ROOT	O
with	IN	case	O
tumorigenicity	NN	nmod	O
.	.	punct	O

Transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
beta	NN	nsubj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promotes	VBZ	ROOT	O
spontaneous	JJ	amod	O
transformation	NN	dobj	O
of	IN	case	O
cultured	VBN	amod	O
rat	NN	compound	B-Organism
liver	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

After	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
gluconeogenesis	NN	nmod	O
,	,	punct	O
the	DT	det	O
plasma	NN	compound	B-Organism_substance
glucose	NN	nsubj	B-Simple_chemical
decreased	VBD	ROOT	O
and	CC	cc	O
the	DT	det	O
blood	NN	compound	B-Organism_substance
lactate	NN	nsubj	B-Simple_chemical
increased	VBD	conj	O
significantly	RB	advmod	O
more	JJR	advmod	O
in	IN	case	O
TB	NN	nmod	O
than	IN	case	O
NTB	NN	compound	O
animals	NNS	nmod	O
.	.	punct	O

SWAP	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
by	IN	case	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Src	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
mouse	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
.	.	punct	O

It	PRP	nsubj	O
involves	VBZ	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
activation	NN	dobj	O
,	,	punct	O
basal	JJ	amod	B-Cellular_component
membrane	NN	compound	I-Cellular_component
degradation	NN	conj	O
,	,	punct	O
leukocyte	NN	compound	B-Cell
invasion	NN	conj	O
,	,	punct	O
proliferation	NN	appos	O
of	IN	case	O
vascular	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
neointima	NN	compound	B-Tissue
formation	NN	appos	O
(	-LRB-	punct	O
in	IN	case	O
most	JJS	amod	O
species	NNS	nmod	O
studied	VBN	acl	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
changes	NNS	conj	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
.	.	punct	O

For	IN	ROOT	O
the	DT	det	O
purpose	NN	pobj	O
of	IN	prep	O
investigating	VBG	pcomp	O
the	DT	det	O
relationship	NN	dobj	O
between	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
potential	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod	B-Cancer
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
,	,	punct	O
and	CC	cc	O
for	IN	prep	O
determing	VBG	pcomp	O
the	DT	det	O
location	NN	dobj	O
of	IN	case	O
the	DT	det	O
positive	JJ	amod	O
sites	NNS	nmod	O
in	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
,	,	punct	O
tumor	NN	compound	B-Cancer
metastasis	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
nm23	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
H1	NN	nsubjpass	I-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
hepatocellular	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
and	CC	cc	O
the	DT	det	O
nonneoplastic	JJ	amod	B-Multi-tissue_structure
area	NN	conj	I-Multi-tissue_structure
surrounding	VBG	acl	O
the	DT	det	O
tumor	NN	dobj	B-Cancer
)	-RRB-	punct	O
was	VBD	auxpass	O
detected	VBN	conj	O
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nmod	O
using	VBG	acl	O
digoxiginin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
labeled	VBN	amod	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
antisense	JJ	amod	O
complementary	JJ	amod	O
RNA	NN	compound	O
probe	NN	dobj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
current	JJ	amod	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
sensitivity	NN	dobj	O
of	IN	case	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
overexpressing	VBG	amod	O
cells	NNS	nmod	O
(	-LRB-	punct	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
to	IN	case	O
two	CD	nummod	O
additional	JJ	amod	O
chemicals	NNS	nmod	O
:	:	punct	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
azacytidine	NN	dep	I-Simple_chemical
and	CC	cc	O
MnSO4	NN	conj	B-Simple_chemical
.	.	punct	O

Only	RB	advmod	O
a	DT	det	O
subset	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
is	VBZ	cop	O
suitable	JJ	ROOT	O
for	IN	case	O
laser	NN	compound	O
coagulation	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
retroviral	JJ	amod	O
gene	NN	compound	O
transfer	NN	compound	O
approach	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
constitutive	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
MEK5	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ERK5	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
strongly	RB	advmod	O
inhibits	VBZ	ccomp	O
EC	NN	compound	B-Cell
migration	NN	dobj	O
and	CC	cc	O
results	VBZ	conj	O
in	IN	case	O
massive	JJ	amod	O
morphological	JJ	amod	O
changes	NNS	nmod	O
.	.	punct	O

p63	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
carcinomas	NNS	nsubjpass	O
were	VBD	auxpass	O
poorly	RB	advmod	O
differentiated	VBN	amod	O
,	,	punct	O
hormone	NN	compound	O
receptor	NN	nmod:npmod	O
-	HYPH	punct	O
negative	JJ	amod	O
neoplasms	NNS	ROOT	B-Cancer
with	IN	case	O
a	DT	det	O
high	JJ	amod	O
proliferation	NN	compound	O
rate	NN	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
,	,	punct	O
furthermore	RB	advmod	O
,	,	punct	O
no	DT	neg	O
correlation	NN	nsubj	O
between	IN	case	O
the	DT	det	O
heterogeneity	NN	nmod	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
the	DT	det	O
patients	NNS	compound	B-Organism
survival	NN	conj	O
.	.	punct	O

In	IN	case	O
nonischemic	JJ	amod	O
hind	NN	amod	B-Tissue
limb	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
,	,	punct	O
allogeneic	JJ	amod	O
FM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	compound	I-Cell
and	CC	cc	O
BM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	compound	I-Cell
injection	NN	nsubjpass	O
were	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
comparatively	RB	advmod	O
small	JJ	amod	O
amount	NN	nmod	O
of	IN	case	O
T	NN	compound	B-Cell
lymphocyte	NN	compound	I-Cell
infiltration	NN	nmod	O
,	,	punct	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
injection	NN	advcl	O
of	IN	case	O
allogeneic	JJ	amod	O
splenic	JJ	amod	B-Cell
lymphocytes	NNS	nmod	I-Cell
.	.	punct	O

Apoptosis	NN	nsubjpass	O
is	VBZ	auxpass	O
detected	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
TUNEL	NN	compound	O
method	NN	nmod	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
the	DT	det	O
angiogenic	JJ	amod	O
and	CC	cc	O
lymphangiogenic	JJ	conj	O
profiles	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
tumors	NNS	nmod	B-Cancer
were	VBD	auxpass	O
characterized	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
down	JJ	amod	O
-	HYPH	punct	O
regulation	NN	nsubj	O
of	IN	case	O
p21WAF1	JJ	nmod	B-Gene_or_gene_product
closely	RB	advmod	O
correlated	VBD	ROOT	O
with	IN	case	O
poly	NN	amod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ADP	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ribose	NN	amod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
polymerase	NN	compound	I-Gene_or_gene_product
cleavage	NN	nmod	O
and	CC	cc	O
CPP32	NN	compound	B-Gene_or_gene_product
activation	NN	conj	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
injected	VBN	advcl	O
into	IN	case	O
chicken	NN	compound	B-Organism
embryos	NNS	nmod	B-Developing_anatomical_structure
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
helper	NN	compound	O
virus	NN	nmod	O
,	,	punct	O
both	DT	det	O
viruses	NNS	nsubj	O
induced	VBD	ROOT	O
an	DT	det	O
erythroleukemia	NN	dobj	B-Cancer
in	IN	case	O
about	RB	advmod	O
half	NN	nmod	O
of	IN	prep	O
the	DT	det	O
animals	NNS	pobj	O
.	.	punct	O

SVLT	NN	compound	B-Gene_or_gene_product
mutants	NNS	nsubjpass	O
,	,	punct	O
defective	JJ	amod	O
either	CC	advmod	O
in	IN	case	O
the	DT	det	O
Rb	NN	compound	B-Gene_or_gene_product
binding	NN	compound	O
site	NN	nmod	O
,	,	punct	O
near	IN	case	O
the	DT	det	O
N	NN	nmod:npmod	O
-	HYPH	punct	O
terminal	JJ	amod	O
end	NN	nmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
region	NN	nmod	O
that	WDT	nsubj	O
affects	VBZ	acl:relcl	O
binding	VBG	dobj	O
to	TO	case	O
p53	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
in	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
transport	NN	compound	O
signal	NN	conj	O
,	,	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
employed	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
the	DT	det	O
interference	NN	nsubj	O
was	VBD	cop	O
especially	RB	advmod	O
dependent	JJ	ccomp	O
on	IN	case	O
these	DT	det	O
functional	JJ	amod	O
domains	NNS	nmod	O
.	.	punct	O

Pathological	JJ	amod	O
analysis	NN	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
generated	VBN	amod	O
tumors	NNS	nsubj	B-Cancer
corresponded	VBD	ccomp	O
to	TO	case	O
well	RB	advmod	O
-	HYPH	punct	O
differentiated	VBN	amod	O
fibrosarcomas	NNS	nmod	B-Cancer
with	IN	case	O
distinct	JJ	amod	O
and	CC	cc	O
intersecting	VBG	conj	O
bundles	NNS	nmod	B-Cell
and	CC	cc	O
spindle	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

MET	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
rarely	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	O
human	JJ	amod	B-Organism
melanoma	NN	nmod	B-Cancer
but	CC	cc	O
is	VBZ	auxpass	O
frequently	RB	advmod	O
observed	VBN	conj	O
in	IN	case	O
metastatic	JJ	amod	B-Cancer
disease	NN	nmod	I-Cancer
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Hyp	NN	nsubj	B-Simple_chemical
is	VBZ	cop	O
a	DT	det	O
powerful	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
compound	NN	ccomp	O
with	IN	case	O
therapeutic	JJ	amod	O
potential	NN	nmod	O
,	,	punct	O
and	CC	cc	O
they	PRP	nsubj	O
elucidate	VBP	conj	O
mechanistic	JJ	amod	O
keys	NNS	dobj	O
.	.	punct	O

In	IN	case	O
seven	CD	nummod	O
diabetic	JJ	amod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
proliferative	JJ	amod	O
retinopathy	NN	nmod	O
,	,	punct	O
the	DT	det	O
most	RBS	advmod	O
profound	JJ	amod	O
finding	NN	nsubj	O
was	VBD	cop	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	ROOT	O
of	IN	case	O
the	DT	det	O
PEDF	NN	compound	B-Gene_or_gene_product
level	NN	nmod	O
(	-LRB-	punct	O
mean	NN	amod	O
value	NN	dep	O
:	:	punct	O
237	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
VEGF	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubj	O
were	VBD	cop	O
comparable	JJ	parataxis	O
to	TO	case	O
diabetic	JJ	amod	O
patients	NNS	nmod	B-Organism
without	IN	case	O
proliferation	NN	nmod	O
(	-LRB-	punct	O
mean	NN	amod	O
value	NN	nmod	O
:	:	punct	O
3153	CD	dep	O
;	:	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
003	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Reconstitution	NN	nsubj	O
of	IN	case	O
MCF	NNP	compound	B-Organism_substance
-	HYPH	punct	I-Organism_substance
7	CD	nummod	I-Organism_substance
cell	NN	compound	I-Organism_substance
extracts	NNS	nmod	I-Organism_substance
with	IN	case	O
procaspase	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
corrects	VBZ	ROOT	O
this	DT	det	O
defect	NN	dobj	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
an	DT	det	O
efficient	JJ	amod	O
and	CC	cc	O
complete	JJ	conj	O
processing	NN	nmod	O
of	IN	case	O
procaspase	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
thalidomide	NN	nmod	B-Simple_chemical
affecting	VBG	acl	O
VEGF	NN	compound	B-Gene_or_gene_product
secretion	NN	dobj	O
,	,	punct	O
cell	NN	compound	B-Cell
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
and	CC	cc	O
capillary	JJ	amod	B-Tissue
tube	NN	compound	I-Tissue
formation	NN	conj	O
of	IN	case	O
human	JJ	amod	B-Organism
endothelial	JJ	amod	B-Cell
EA	NN	nmod	I-Cell
.	.	punct	I-Cell
hy	NN	dep	I-Cell
926	CD	nummod	I-Cell
cells	NNS	ROOT	I-Cell
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
recognized	VBN	ROOT	O
as	IN	case	O
the	DT	det	O
cause	NN	nmod	O
of	IN	case	O
adult	JJ	amod	B-Cancer
T	NN	compound	I-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
leukemia	NN	nmod	I-Cancer
(	-LRB-	punct	O
ATL	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Their	PRP$	nmod:poss	O
relevance	NN	ROOT	O
in	IN	case	O
cancer	NN	compound	B-Cancer
prevention	NN	nmod	O
.	.	punct	O

Accordingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
therapeutic	JJ	amod	O
potential	NN	nsubj	O
of	IN	case	O
curcumin	NN	nmod	B-Simple_chemical
for	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
deserves	VBZ	ROOT	O
further	JJ	amod	O
study	NN	dobj	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
C	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
C	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
lymphangiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
is	VBZ	auxpass	O
implicated	VBN	conj	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
.	.	punct	O

The	DT	det	O
prevailing	VBG	amod	O
model	NN	nsubj	O
for	IN	case	O
Notch	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
ligand	NN	nsubj	O
,	,	punct	O
presented	VBN	acl	O
on	IN	case	O
a	DT	det	O
neighboring	JJ	amod	O
cell	NN	nmod	B-Cell
,	,	punct	O
triggers	VBZ	ccomp	O
proteolytic	JJ	amod	O
processing	NN	dobj	O
of	IN	case	O
Notch	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
antitumor	JJ	compound	B-Cancer
agents	NNS	nmod	O
on	IN	case	O
cytotoxicity	NN	compound	O
induction	NN	nmod	O
by	IN	case	O
sodium	NN	compound	B-Simple_chemical
fluoride	NN	nmod	I-Simple_chemical
.	.	punct	O

Neoplastic	JJ	amod	O
transformation	NN	nsubj	O
by	IN	case	O
Notch	NN	nmod	B-Gene_or_gene_product
requires	VBZ	ROOT	O
nuclear	JJ	amod	B-Cellular_component
localization	NN	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
osteoprotegerin	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
OPG	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
inhibits	VBZ	ROOT	O
osteoclast	JJ	compound	B-Cell
development	NN	dobj	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
and	CC	cc	O
clinical	JJ	amod	O
significance	NN	conj	O
of	IN	case	O
Merlin	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
in	IN	case	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
(	-LRB-	punct	O
NSCLC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
ITCs	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
observed	VBN	dep	O
in	IN	case	O
peripheral	JJ	amod	B-Organism_substance
blood	NN	nmod	I-Organism_substance
and	CC	cc	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	conj	I-Multi-tissue_structure
even	RB	advmod	O
in	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Collagen	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
poly	JJ	amod	B-Simple_chemical
glycolic	JJ	amod	I-Simple_chemical
acid	NN	compound	I-Simple_chemical
hybrid	NN	compound	O
matrix	NN	nsubj	O
with	IN	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
accelerated	VBD	ROOT	O
angiogenesis	NN	dobj	O
and	CC	cc	O
granulation	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
formation	NN	conj	O
in	IN	case	O
diabetic	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

To	TO	mark	O
evaluate	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
developed	VBD	ROOT	O
an	DT	det	O
animal	NN	compound	O
model	NN	dobj	O
by	IN	mark	O
using	VBG	advcl	O
an	DT	det	O
endometrial	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	dobj	I-Cell
,	,	punct	O
HEC1A	NN	appos	B-Cell
.	.	punct	O

In	IN	case	O
uremic	JJ	amod	O
patients	NNS	nmod	B-Organism
,	,	punct	O
NOS	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
positively	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
duration	NN	nmod	O
of	IN	case	O
PD	NN	nmod	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
how	WRB	advmod	O
p18	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
p27	NN	conj	B-Gene_or_gene_product
genetically	RB	advmod	O
interact	VBP	ccomp	O
with	IN	case	O
Men1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	appos	O
mutated	VBN	acl	O
in	IN	case	O
familial	JJ	amod	O
MEN1	NN	nmod	B-Cancer
,	,	punct	O
we	PRP	nsubj	O
characterized	VBD	ROOT	O
p18	NN	compound	B-Gene_or_gene_product
-	:	punct	O
Men1	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
p27	NN	compound	B-Gene_or_gene_product
-	:	punct	O
Men1	NN	conj	B-Gene_or_gene_product
double	JJ	amod	O
mutant	JJ	amod	O
mice	NNS	dep	O
.	.	punct	O

When	WRB	advmod	O
a	DT	det	O
confluent	JJ	amod	O
monolayer	NN	nsubjpass	B-Cell
of	IN	case	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
ECV304	NN	appos	B-Cell
,	,	punct	O
was	VBD	auxpass	O
denuded	VBN	advcl	O
,	,	punct	O
ECV304	NN	nsubj	B-Cell
at	IN	case	O
the	DT	det	O
wound	NN	compound	B-Pathological_formation
edge	NN	nmod	I-Pathological_formation
expressed	VBD	ROOT	O
Ets	NN	dobj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Opticin	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
recently	RB	advmod	O
discovered	VBN	amod	O
glycoprotein	NN	appos	O
present	JJ	amod	O
predominantly	RB	advmod	O
in	IN	case	O
the	DT	det	O
vitreous	JJ	amod	B-Organism_substance
humour	NN	nmod	I-Organism_substance
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
demonstrate	VBP	ROOT	O
direct	JJ	amod	O
interaction	NN	dobj	O
of	IN	case	O
Egr	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
with	IN	case	O
Id	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promoter	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
in	IN	case	O
cell	NN	compound	B-Cell
culture	NN	conj	I-Cell
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
A	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nsubjpass	O
,	,	punct	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	appos	I-Gene_or_gene_product
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
purified	VBN	dep	O
from	IN	prep	O
the	DT	det	O
cartilage	NN	pobj	B-Tissue
of	IN	prep	O
the	DT	det	O
blue	JJ	amod	B-Organism
shark	NN	pobj	I-Organism
(	-LRB-	punct	O
Prionace	NN	compound	B-Organism
glauca	NN	appos	I-Organism
)	-RRB-	punct	O
.	.	punct	O

This	DT	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
substantial	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
P185neu	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
led	VBD	acl:relcl	O
to	TO	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
progressively	RB	advmod	O
growing	VBG	amod	O
carcinomas	NNS	nmod	B-Cancer
after	IN	case	O
such	JJ	amod	O
cells	NNS	nmod	B-Cell
were	VBD	auxpass	O
inoculated	VBN	conj	O
into	IN	case	O
athymic	JJ	amod	O
nude	JJ	compound	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

Plasmid	NN	amod	B-Cellular_component
DNA	NN	nsubjpass	I-Cellular_component
encoding	VBG	acl	O
each	DT	dobj	O
of	IN	case	O
the	DT	det	O
three	CD	nummod	O
principal	JJ	amod	O
human	JJ	amod	B-Organism
VEGF	NN	compound	B-Gene_or_gene_product
isoforms	NNS	nmod	O
(	-LRB-	punct	O
phVEGF121	NN	dep	B-Gene_or_gene_product
,	,	punct	O
phVEGF165	NN	conj	B-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
phVEGF189	NN	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
was	VBD	auxpass	O
applied	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
hydrogel	NN	compound	O
polymer	NN	nmod	O
coating	VBG	acl	O
of	IN	case	O
an	DT	det	O
angioplasty	JJ	amod	O
balloon	NN	nmod	O
and	CC	cc	O
delivered	VBN	conj	O
percutaneously	RB	advmod	O
to	IN	case	O
one	CD	nummod	O
iliac	JJ	compound	B-Multi-tissue_structure
artery	NN	nmod	I-Multi-tissue_structure
of	IN	case	O
rabbits	NNS	nmod	B-Organism
with	IN	case	O
operatively	RB	advmod	O
induced	VBN	amod	O
hindlimb	JJ	compound	B-Organism_subdivision
ischemia	NN	nmod	O
.	.	punct	O

LDH5	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubj	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
induces	VBZ	ROOT	O
an	DT	det	O
upregulated	VBN	amod	O
glycolytic	JJ	amod	O
metabolism	NN	dobj	O
and	CC	cc	O
reduced	VBN	amod	O
dependence	NN	conj	O
on	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
oxygen	NN	nmod	B-Simple_chemical
.	.	punct	O

Functional	JJ	amod	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
Sema7A	NN	nsubj	B-Gene_or_gene_product
stimulates	VBZ	ccomp	O
cytoskeletal	JJ	amod	B-Cellular_component
reorganization	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
melanocytes	NNS	nmod	B-Cell
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
adhesion	NN	nmod	O
and	CC	cc	O
dendrite	NN	compound	B-Cellular_component
formation	NN	conj	O
.	.	punct	O

Because	IN	mark	O
thrombin	NN	compound	B-Gene_or_gene_product
cleavage	NN	nsubj	O
of	IN	case	O
OPN	NN	compound	B-Gene_or_gene_product
results	VBZ	nmod	O
in	IN	case	O
substantial	JJ	amod	O
enhancement	NN	nmod	O
of	IN	case	O
OPN	NN	nmod:poss	B-Gene_or_gene_product
'	POS	punct	O
s	VBZ	compound	O
adhesive	JJ	amod	O
properties	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
because	IN	mark	O
VPF	NNP	nsubj	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	nsubj	B-Gene_or_gene_product
promotes	VBZ	conj	O
increased	VBD	amod	O
microvascular	JJ	amod	B-Tissue
permeability	NN	dobj	O
leading	VBG	acl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
extrinsic	JJ	amod	O
coagulation	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
also	RB	advmod	O
investigated	VBD	ROOT	O
whether	IN	mark	O
VPF	NNP	nsubj	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	conj	B-Gene_or_gene_product
facilitates	NNS	ccomp	O
thrombin	NN	compound	B-Gene_or_gene_product
cleavage	NN	dobj	O
of	IN	case	O
OPN	NN	nmod	B-Gene_or_gene_product
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
findings	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
tissue	NN	compound	B-Cancer
samples	NNS	nmod	I-Cancer
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
with	IN	case	O
regard	NN	nmod	O
to	TO	case	O
the	DT	det	O
patients	NNS	nmod:poss	B-Organism
'	POS	case	O
risk	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
course	NN	conj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
MSCs	NNS	nsubjpass	B-Cell
from	IN	case	O
Sprague	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Dawley	NNP	compound	I-Organism
(	-LRB-	punct	I-Organism
SD	NN	appos	I-Organism
)	-RRB-	punct	I-Organism
rats	NNS	nmod	I-Organism
were	VBD	auxpass	O
isolated	VBN	dep	O
and	CC	cc	O
cultured	VBN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

These	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	nmod	I-Gene_or_gene_product
may	MD	aux	O
have	VB	ROOT	O
important	JJ	amod	O
regulatory	JJ	amod	O
functions	NNS	dobj	O
in	IN	case	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
composition	NN	nmod	O
,	,	punct	O
wound	NN	compound	B-Pathological_formation
healing	NN	dobj	O
,	,	punct	O
or	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
mutation	NN	nsubj	O
of	IN	case	O
beclin	NN	nmod	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
or	CC	cc	O
other	JJ	amod	O
autophagy	NN	compound	O
genes	NNS	conj	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	mark	O
altering	VBG	acl	O
metastasis	NN	dobj	O
,	,	punct	O
beta	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
levels	NNS	nsubj	O
control	VBP	ROOT	O
tumor	NN	compound	B-Cancer
differentiation	NN	dobj	O
and	CC	cc	O
regulate	VB	conj	O
both	CC	cc:preconj	O
MAPK	NN	dobj	B-Gene_or_gene_product
/	:	punct	O
Erk	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
PI3K	NN	conj	B-Gene_or_gene_product
/	:	punct	O
Akt	NN	compound	B-Gene_or_gene_product
signaling	NN	conj	O
.	.	punct	O

The	DT	det	O
semaphorin	NN	compound	B-Gene_or_gene_product
7A	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	O
Plexin	NN	compound	B-Gene_or_gene_product
C1	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
lost	VBN	ROOT	O
during	IN	case	O
melanoma	NN	compound	B-Cancer
metastasis	NN	nmod	O
.	.	punct	O

Eleven	CD	amod	O
genes	NNS	nsubjpass	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
whose	WP$	nmod:poss	O
expression	NN	nsubj	O
changed	VBD	ccomp	O
significantly	RB	advmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
carcinogen	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

There	EX	expl	O
have	VBP	aux	O
been	VBN	ROOT	O
no	DT	det	O
reports	NNS	attr	O
showing	VBG	acl	O
the	DT	det	O
relativity	NN	dobj	O
of	IN	case	O
invasive	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
the	DT	det	O
desmoplastic	JJ	amod	O
reaction	NN	conj	O
by	IN	case	O
a	DT	det	O
quantitative	JJ	amod	O
analysis	NN	nmod	O
of	IN	prep	O
the	DT	det	O
myofibroblasts	NNS	pobj	B-Cell
that	WDT	nsubj	O
were	VBD	relcl	O
an	DT	det	O
important	JJ	amod	O
player	NN	attr	O
in	IN	prep	O
the	DT	det	O
desmoplastic	JJ	amod	O
reaction	NN	pobj	O
.	.	punct	O

Medical	JJ	amod	O
therapy	NN	ROOT	O
for	IN	case	O
intermittent	JJ	amod	O
claudication	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
adenosine	NN	nsubj	B-Simple_chemical
could	MD	aux	O
modulate	VB	ccomp	O
the	DT	det	O
migration	NN	dobj	O
of	IN	case	O
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
an	DT	det	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
/	:	punct	O
VEGF	NN	conj	B-Gene_or_gene_product
/	:	punct	O
IL	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
mechanism	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
caffeine	NN	nsubj	B-Simple_chemical
has	VBZ	conj	O
the	DT	det	O
potential	NN	dobj	O
to	TO	mark	O
inhibit	VB	acl	O
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
Bax	NN	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
Bak	NN	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
rapidly	RB	advmod	O
translocated	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
mitochondria	NN	nmod	B-Cellular_component
30	CD	nummod	O
min	NN	dep	O
after	IN	case	O
betulin	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
suggested	VBD	ROOT	O
that	IN	mark	O
either	CC	cc:preconj	O
the	DT	det	O
structural	JJ	nsubjpass	O
or	CC	cc	O
the	DT	det	O
functional	JJ	amod	O
integrity	NN	conj	O
of	IN	case	O
the	DT	det	O
J	NN	compound	O
domain	NN	nmod	O
is	VBZ	auxpass	O
required	VBN	ccomp	O
to	TO	mark	O
sensitize	VB	xcomp	O
cells	NNS	dobj	B-Cell
to	TO	case	O
apoptosis	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
invasion	NN	nsubjpass	O
,	,	punct	O
apoptosis	NN	conj	O
and	CC	cc	O
levels	NNS	conj	O
of	IN	case	O
uPA	NN	compound	B-Gene_or_gene_product
,	,	punct	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nmod	I-Gene_or_gene_product
were	VBD	auxpass	O
determined	VBN	dep	O
by	IN	case	O
invasion	NN	compound	O
assay	NN	nmod	O
,	,	punct	O
flow	NN	compound	O
cytometry	NN	conj	O
,	,	punct	O
Western	NN	compound	O
blot	NN	appos	O
and	CC	cc	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
fluorescence	NN	compound	O
quantitative	JJ	amod	O
PCR	NN	conj	O
respectively	RB	advmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
laboratory	NN	nsubj	O
has	VBZ	aux	O
provided	VBN	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
thrombin	NN	nsubj	B-Gene_or_gene_product
activates	VBZ	ccomp	O
angiogenesis	NN	dobj	O
,	,	punct	O
a	DT	det	O
process	NN	dobj	O
which	WDT	nsubj	O
is	VBZ	cop	O
essential	JJ	acl:relcl	O
in	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

The	DT	det	O
more	RBR	advmod	O
pronounced	JJ	amod	O
effects	NNS	nsubj	O
of	IN	case	O
Bmi	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
over	IN	dep	O
-	HYPH	punct	O
expression	NN	nmod	O
in	IN	case	O
culture	NN	nmod	O
were	VBD	cop	O
largely	RB	advmod	O
attributable	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
attenuated	VBN	amod	O
induction	NN	nmod	O
of	IN	case	O
p16	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
Ink4a	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
p19	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
Arf	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
culture	NN	nmod	O
,	,	punct	O
proteins	NNS	dep	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
generally	RB	advmod	O
not	RB	neg	O
expressed	VBN	acl:relcl	O
by	IN	case	O
neural	JJ	amod	B-Cell
stem	NN	compound	I-Cell
/	:	punct	I-Cell
progenitor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
young	JJ	amod	O
mice	NNS	nmod	B-Organism
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
unclear	JJ	ROOT	O
whether	IN	mark	O
sunitinib	NN	nsubj	B-Simple_chemical
acts	VBZ	ccomp	O
only	RB	advmod	O
through	IN	case	O
an	DT	det	O
antiangiogenic	JJ	amod	O
mechanism	NN	nmod	O
or	CC	cc	O
whether	IN	mark	O
it	PRP	nsubj	O
may	MD	aux	O
also	RB	advmod	O
directly	RB	advmod	O
target	VB	conj	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

A	DT	det	O
significant	JJ	amod	O
amount	NN	nsubjpass	O
of	IN	case	O
type	NN	compound	B-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
HK	NN	compound	I-Gene_or_gene_product
RNA	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
expressed	VBN	xcomp	O
in	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

Normal	JJ	amod	O
and	CC	cc	O
transforming	VBG	conj	O
functions	NNS	ROOT	O
of	IN	case	O
RUNX1	NN	nmod	B-Gene_or_gene_product
:	:	punct	O
a	DT	det	O
perspective	NN	dep	O
.	.	punct	O

Injection	NN	nsubj	O
of	IN	case	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
neutralizing	VBG	amod	O
antibodies	NNS	nmod	O
over	IN	case	O
a	DT	det	O
2	CD	nummod	O
-	HYPH	punct	O
week	NN	compound	O
period	NN	nmod	O
completely	RB	advmod	O
blocked	VBD	ROOT	O
alinidine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
stimulated	VBN	amod	O
angiogenesis	NN	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
gonadotropin	NN	nsubj	B-Gene_or_gene_product
-	HYPH	punct	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
estrogen	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
mediated	VBN	amod	O
maintenance	NN	nsubj	O
of	IN	case	O
SEMA3	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
could	MD	aux	O
control	VB	ROOT	O
ovarian	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
angiogenesis	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
a	DT	det	O
selective	JJ	amod	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
inhibitor	NN	nsubj	O
,	,	punct	O
SC	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
560	CD	appos	I-Simple_chemical
,	,	punct	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
serum	NN	compound	B-Organism_substance
progesterone	NN	compound	B-Simple_chemical
concentrations	NNS	nmod	O
.	.	punct	O

Elevated	JJ	amod	O
serum	NN	compound	B-Organism_substance
soluble	JJ	amod	O
VAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
levels	NNS	nsubj	O
occur	VBP	ROOT	O
in	IN	case	O
certain	JJ	amod	O
diseases	NNS	nmod	O
having	VBG	acl	O
an	DT	det	O
inflammatory	JJ	amod	O
component	NN	dobj	O
.	.	punct	O

In	IN	case	O
cultured	VBN	amod	O
b	NN	ROOT	B-Cell
.	.	punct	I-Cell
END5	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
the	DT	det	O
tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
alpha	NN	nsubj	I-Gene_or_gene_product
-	:	punct	O
induced	VBN	ROOT	O
up	RP	advmod	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
intercellular	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	conj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
was	VBD	auxpass	O
reduced	VBN	conj	O
in	IN	case	O
ECs	NNS	nmod	B-Cell
that	WDT	nsubjpass	O
were	VBD	auxpass	O
preincubated	VBN	acl:relcl	O
with	IN	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
PTEN	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
methylation	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
surgical	JJ	amod	O
specimens	NNS	nmod	O
of	IN	case	O
CCMs	NNS	nmod	B-Pathological_formation
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
69	CD	dep	O
)	-RRB-	punct	O
by	IN	case	O
methylation	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
.	.	punct	O

Tetracyclines	NNS	nsubj	B-Simple_chemical
are	VBP	ROOT	O
antimicrobial	JJ	amod	O
agents	NNS	attr	O
that	WDT	nsubj	O
can	MD	aux	O
suppress	VB	acl:relcl	O
MP	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
tissues	NNS	nmod	B-Tissue
,	,	punct	O
including	VBG	case	O
gingiva	NN	nmod	B-Multi-tissue_structure
,	,	punct	O
bone	NN	conj	B-Tissue
,	,	punct	O
and	CC	cc	O
cartilage	NN	conj	B-Tissue
.	.	punct	O

Differential	JJ	amod	O
mechanisms	NNS	ROOT	O
of	IN	case	O
radiosensitization	NN	nmod	O
by	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
D	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
glucose	NN	nmod	I-Simple_chemical
in	IN	case	O
the	DT	det	O
monolayers	NNS	nmod	B-Cell
and	CC	cc	O
multicellular	JJ	amod	B-Cell
spheroids	NNS	conj	I-Cell
of	IN	case	O
a	DT	det	O
human	JJ	amod	B-Organism
glioma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
.	.	punct	O

Growth	NN	nsubjpass	O
of	IN	case	O
both	DT	det	O
histologic	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
gene	NN	nmod:npmod	O
-	HYPH	punct	O
modified	VBN	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
severe	JJ	amod	O
combined	JJ	amod	O
immunodeficiency	NN	compound	O
(	-LRB-	punct	O
SCID	NN	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	B-Organism
was	VBD	auxpass	O
significantly	RB	advmod	O
restricted	JJ	ROOT	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

ECs	NNS	nsubj	B-Cell
on	IN	prep	O
15	CD	nummod	O
-	HYPH	punct	O
microm	JJ	amod	O
wide	JJ	amod	O
strips	NNS	pobj	O
had	VBD	ROOT	O
highest	JJS	amod	O
speed	NN	dobj	O
,	,	punct	O
particularly	RB	advmod	O
in	IN	prep	O
the	DT	det	O
direction	NN	pobj	O
of	IN	prep	O
the	DT	det	O
strip	NN	pobj	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
enhanced	VBD	ROOT	O
killing	NN	dobj	O
of	IN	case	O
myeloid	JJ	amod	B-Cell
leukemia	NN	compound	I-Cell
U937	NN	nmod	I-Cell
,	,	punct	O
cervical	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
HeLa	NN	conj	I-Cell
,	,	punct	O
and	CC	cc	O
breast	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
MCF	NNP	compound	I-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	conj	I-Cell
upon	IN	case	O
death	NN	compound	O
receptor	NN	compound	O
ligation	NN	nmod	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
bolus	NN	compound	O
(	-LRB-	punct	O
3h	NN	compound	O
)	-RRB-	punct	O
doxorubicin	NN	compound	B-Simple_chemical
incubation	NN	nsubj	O
led	VBD	ROOT	O
to	TO	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
at	IN	case	O
serine	NN	nmod	B-Amino_acid
392	CD	nummod	I-Amino_acid
,	,	punct	O
induction	NN	conj	O
of	IN	case	O
p21	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
G2	NN	compound	O
arrest	NN	conj	O
and	CC	cc	O
increase	NN	conj	O
of	IN	case	O
proapoptotic	JJ	amod	O
protein	NN	compound	O
Bax	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Untransformed	JJ	amod	O
CEF	NN	nsubj	B-Cell
and	CC	cc	O
CEF	NN	conj	B-Cell
transformed	VBN	acl	O
with	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod	I-Organism
also	RB	advmod	O
migrated	VBD	ROOT	O
to	TO	case	O
9E3	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CEF4	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
Boyden	NNP	compound	O
single	JJ	amod	O
-	HYPH	punct	O
membrane	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
may	MD	aux	O
play	VB	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
high	JJ	amod	O
proliferative	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
in	IN	case	O
the	DT	det	O
RSCM	NN	compound	B-Cancer
group	NN	nmod	O
and	CC	cc	O
H	NN	conj	B-Organism
.	.	punct	I-Organism
pylori	NNS	compound	I-Organism
infection	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
closely	RB	advmod	O
related	JJ	ROOT	O
to	TO	case	O
carcinogenesis	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
RSC	NN	nmod	B-Cancer
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
these	DT	det	O
cell	NN	compound	B-Cell
lines	NNS	dobj	I-Cell
and	CC	cc	O
samples	NNS	conj	B-Tissue
from	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
by	IN	case	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	dobj	O
for	IN	case	O
the	DT	det	O
expressions	NNS	nmod	O
of	IN	case	O
OPG	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
RANKL	NN	conj	B-Gene_or_gene_product
mRNA	NN	nmod	O
.	.	punct	O

Non	NNP	compound	O
-	HYPH	punct	O
invasive	JJ	amod	O
grading	NN	nsubj	O
of	IN	prep	O
primary	JJ	amod	O
brain	NN	pobj	B-Cancer
tumours	NNS	ROOT	I-Cancer
:	:	punct	O
results	NNS	dep	O
of	IN	case	O
a	DT	det	O
comparative	JJ	amod	O
study	NN	nmod	O
between	IN	case	O
SPET	NN	nmod	O
with	IN	case	O
123I	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
alpha	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
tyrosine	NN	nmod	I-Simple_chemical
and	CC	cc	O
PET	NN	conj	O
with	IN	case	O
18F	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxyglucose	NN	nmod	I-Simple_chemical
.	.	punct	O

HT	NN	compound	B-Cell
-	HYPH	punct	I-Cell
29	CD	nummod	I-Cell
human	JJ	amod	B-Organism
colorectal	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
xenograft	NN	compound	I-Cancer
model	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
and	CC	cc	O
tumour	NN	compound	B-Cancer
growth	NN	conj	O
,	,	punct	O
microvessel	NN	compound	B-Tissue
density	NN	conj	O
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product
quantification	NN	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	conj	O
in	IN	case	O
tumours	NNS	nmod	B-Cancer
after	IN	case	O
the	DT	det	O
administration	NN	nmod	O
of	IN	case	O
metronomic	JJ	amod	O
CPT	NN	nmod	B-Simple_chemical
-	:	punct	I-Simple_chemical
11	CD	dep	I-Simple_chemical
,	,	punct	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OHP	NNP	conj	I-Simple_chemical
,	,	punct	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	dep	I-Simple_chemical
and	CC	cc	O
their	PRP$	nmod:poss	O
simultaneous	JJ	amod	O
combination	NN	conj	O
.	.	punct	O

All	DT	nsubj	O
of	IN	case	O
the	DT	det	O
clones	NNS	nmod	B-Cell
in	IN	case	O
culture	NN	nmod	O
showed	VBD	ROOT	O
almost	RB	advmod	O
the	DT	det	O
same	JJ	amod	O
low	JJ	amod	O
level	NN	dobj	O
of	IN	case	O
metastatic	JJ	amod	O
ability	NN	nmod	O
and	CC	cc	O
exhibited	VBD	conj	O
little	JJ	amod	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	compound	O
amplification	NN	dobj	O
with	IN	case	O
correspondingly	RB	advmod	O
low	JJ	amod	O
mRNA	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Oxygent	JJ	amod	B-Simple_chemical
perfusion	NN	compound	O
medium	NN	nsubj	O
increased	VBD	ROOT	O
the	DT	det	O
TET	NN	compound	B-Tissue
epithelial	JJ	amod	I-Tissue
PtO	NN	dobj	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
51	CD	dep	O
.	.	punct	O
2	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	appos	O
.	.	punct	O
3	CD	nummod	O
mm	NN	ROOT	O
Hg	NNP	dep	O
vs	CC	cc	O
.	.	punct	O
33	CD	nummod	O
.	.	punct	O
4	CD	meta	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	ROOT	O
.	.	punct	O
3	CD	nummod	O
mm	NN	compound	O
Hg	NN	ROOT	O
at	IN	case	O
200	CD	nummod	O
microm	NN	compound	O
thickness	NN	nmod	O
;	:	punct	O
12	CD	dep	O
.	.	punct	O
5	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
1	CD	nummod	O
mm	NN	compound	O
Hg	NNP	ROOT	O
vs	CC	cc	O
.	.	punct	O
3	LS	nummod	O
.	.	punct	O
1	CD	ROOT	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
1	CD	nummod	O
mm	NN	compound	O
Hg	NN	ROOT	O
at	IN	case	O
400	CD	nummod	O
microm	JJ	compound	O
thickness	NN	nmod	O
,	,	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	nummod	O
.	.	punct	O
01	CD	conj	O
)	-RRB-	punct	O
and	CC	cc	O
decreased	VBD	conj	O
the	DT	det	O
lactate	NN	compound	B-Simple_chemical
concentration	NN	dobj	O
(	-LRB-	punct	O
0	CD	nummod	O
.	.	punct	O
63	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
08	CD	dep	O
vs	CC	cc	O
.	.	punct	O
0	LS	nummod	O
.	.	punct	O
80	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
06	CD	nummod	O
mmol	NN	compound	O
/	:	punct	O
L	NN	dep	O
,	,	punct	O
p	NN	appos	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
lactate	NN	conj	B-Simple_chemical
/	:	punct	O
pyruvate	NN	dep	B-Simple_chemical
(	-LRB-	punct	O
1	CD	nummod	O
.	.	punct	O
87	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
26	CD	dep	O
vs	CC	cc	O
.	.	punct	O
3	LS	nummod	O
.	.	punct	O
36	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
10	CD	dep	O
.	.	punct	O
13	CD	dep	O
,	,	punct	O
p	NN	appos	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
lactate	NN	conj	B-Simple_chemical
/	:	punct	O
glucose	NN	compound	B-Simple_chemical
ratios	NNS	ROOT	O
(	-LRB-	punct	O
0	CD	dep	O
.	.	punct	O
10	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nummod	O
.	.	punct	O
00	CD	dep	O
vs	CC	cc	O
.	.	punct	O
0	LS	nummod	O
.	.	punct	O
29	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
14	CD	dep	O
,	,	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	nmod	O
.	.	punct	O
05	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	nmod	O
or	CC	cc	O
mutant	JJ	amod	O
survivin	NN	conj	B-Gene_or_gene_product
was	VBD	auxpass	O
investigated	VBN	ROOT	O
on	IN	case	O
capillary	JJ	amod	B-Multi-tissue_structure
network	NN	compound	I-Multi-tissue_structure
stability	NN	nmod	O
,	,	punct	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
viability	NN	conj	O
,	,	punct	O
and	CC	cc	O
caspase	NN	compound	B-Gene_or_gene_product
activation	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
on	IN	case	O
kinetics	NNS	conj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
development	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
a	DT	det	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
xenograft	NN	compound	I-Cancer
model	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

On	IN	prep	O
the	DT	det	O
contrary	NN	pobj	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
intense	JJ	amod	O
staining	NN	nsubj	O
for	IN	case	O
HER2	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
the	DT	det	O
basolateral	JJ	amod	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
of	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
intestinal	JJ	amod	B-Cancer
metaplasia	NN	nmod	I-Cancer
(	-LRB-	punct	O
22	CD	nummod	O
/	SYM	punct	O
24	CD	nummod	O
;	:	punct	O
91	CD	dep	O
.	.	punct	O
7	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
carcinoma	NN	conj	B-Cancer
in	FW	compound	O
situ	FW	advmod	O
(	-LRB-	punct	O
9	CD	nummod	O
/	SYM	punct	O
10	CD	dep	O
;	:	punct	O
90	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
lesions	NNS	attr	B-Pathological_formation
that	WDT	nsubj	O
displayed	VBD	acl:relcl	O
a	DT	det	O
significantly	RB	advmod	O
high	JJ	amod	O
proliferation	NN	compound	O
index	NN	dobj	O
.	.	punct	O

Alpha	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
melanocyte	NN	intj	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
stimulating	VBG	amod	I-Gene_or_gene_product
hormone	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
evolved	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
mediator	NN	nmod	O
of	IN	case	O
diverse	JJ	amod	O
biological	JJ	amod	O
activities	NNS	nmod	O
in	IN	case	O
an	DT	det	O
ever	RB	advmod	O
-	HYPH	punct	O
growing	VBG	amod	O
number	NN	nmod	O
of	IN	prep	O
non	JJ	amod	B-Cell
-	HYPH	punct	I-Cell
melanocytic	JJ	amod	I-Cell
cell	NN	compound	I-Cell
types	NNS	pobj	O
.	.	punct	O

To	TO	mark	O
confirm	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
lymphangiogenesis	NN	nmod	O
in	IN	mark	O
mediating	VBG	advcl	O
metastasis	NN	dobj	O
,	,	punct	O
the	DT	det	O
low	JJ	amod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
LAPC	NN	compound	B-Cell
-	:	punct	I-Cell
9	CD	nummod	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
engineered	VBN	ROOT	O
to	TO	mark	O
overexpress	VB	xcomp	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NNP	dobj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
development	NN	nsubjpass	O
of	IN	case	O
metastases	NNS	nmod	B-Cancer
was	VBD	auxpass	O
evaluated	VBN	conj	O
.	.	punct	O

We	PRP	nsubj	O
will	MD	aux	O
also	RB	advmod	O
discuss	VB	ROOT	O
several	JJ	amod	O
patents	NNS	dobj	O
regarding	VBG	case	O
inhibitors	NNS	nmod	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
action	NN	nmod	O
in	IN	case	O
the	DT	det	O
present	JJ	amod	O
review	NN	nmod	O
.	.	punct	O

Proteolytic	JJ	amod	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
turnover	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
during	IN	case	O
wound	NN	compound	B-Pathological_formation
healing	NN	nmod	O
.	.	punct	O

Prognostic	JJ	amod	O
significance	NN	ROOT	O
of	IN	case	O
heat	NN	compound	B-Gene_or_gene_product
shock	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
27	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
HSP27	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Members	NNS	nsubjpass	O
of	IN	prep	O
the	DT	det	O
Runx	NNP	nmod	B-Gene_or_gene_product
and	CC	cc	O
MYC	NN	conj	B-Gene_or_gene_product
families	NNS	pobj	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
as	IN	mark	O
collaborating	VBG	advcl	O
oncogenes	NNS	dobj	O
.	.	punct	O

Thalidomide	NN	compound	B-Simple_chemical
[	-LRB-	punct	O
alpha	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
N	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phthalimido	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
glutarimide	NN	nsubjpass	I-Simple_chemical
]	-RRB-	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	xcomp	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
its	PRP$	nmod:poss	O
inhibitory	JJ	amod	O
action	NN	nmod	O
remains	VBZ	conj	O
unclear	JJ	xcomp	O
.	.	punct	O

The	DT	det	O
oxidative	JJ	amod	O
burst	NN	nsubjpass	O
of	IN	case	O
neutrophils	NNS	nmod	B-Cell
stimulated	VBN	acl	O
by	IN	case	O
Annexin	NN	compound	B-Gene_or_gene_product
V	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
reduced	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
saline	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
MTX	NN	compound	B-Simple_chemical
group	NN	nmod	O
,	,	punct	O
while	IN	mark	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Car	NNP	nsubj	I-Simple_chemical
abolished	VBD	advcl	O
this	DT	det	O
inhibition	NN	dobj	O
.	.	punct	O

Immunostaining	NN	amod	O
data	NNS	nsubjpass	O
are	VBP	auxpass	O
interpreted	VBN	ROOT	O
with	IN	case	O
computer	NN	compound	O
image	NN	compound	O
analysis	NN	nmod	O
and	CC	cc	O
reported	VBN	conj	O
as	IN	case	O
stain	NN	compound	O
index	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Immunohistochemical	JJ	amod	O
and	CC	cc	O
PCR	NN	compound	O
-	:	punct	O
SSCP	NN	conj	O
techniques	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	dep	O
to	TO	mark	O
detect	VB	xcomp	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
exon	NN	compound	O
11	CD	nummod	O
mutation	NN	conj	O
in	IN	case	O
82	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
GIST	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
activation	NN	nsubj	O
of	IN	prep	O
Na	NN	pobj	B-Simple_chemical
+	CC	cc	I-Simple_chemical
transport	NN	conj	O
is	VBZ	cop	O
due	JJ	ROOT	O
to	TO	prep	O
the	DT	det	O
exchange	NN	pobj	O
of	IN	prep	O
protons	NNS	pobj	B-Simple_chemical
formed	VBN	acl	O
via	IN	prep	O
glucose	NN	compound	B-Simple_chemical
conversion	NN	pobj	O
into	IN	prep	O
lactate	NN	pobj	B-Simple_chemical
for	IN	prep	O
Na	NN	pobj	B-Simple_chemical
+	CC	cc	I-Simple_chemical
,	,	punct	O
i	LS	intj	O
.	.	punct	O
e	LS	ROOT	O
.	.	punct	O
,	,	punct	O
to	TO	prep	O
the	DT	det	O
stimulation	NN	pobj	O
of	IN	prep	O
the	DT	det	O
Na	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
/	SYM	punct	O
H	NN	compound	B-Simple_chemical
+	CC	cc	I-Simple_chemical
-	HYPH	punct	O
antiport	NN	pobj	O
.	.	punct	O

In	IN	case	O
damaged	VBN	nmod	O
and	CC	cc	O
inflamed	JJ	conj	O
tissue	NN	conj	B-Tissue
,	,	punct	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	dep	I-Gene_or_gene_product
functions	NNS	nsubj	O
as	IN	case	O
a	DT	det	O
chemoattractant	NN	nmod	O
,	,	punct	O
mitogen	NN	conj	O
and	CC	cc	O
pro	NN	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
factor	NN	conj	O
suggesting	VBG	ROOT	O
that	IN	mark	O
the	DT	det	O
peptide	NN	nsubj	O
may	MD	aux	O
potentiate	VB	ccomp	O
tumor	NN	compound	B-Cancer
progression	NN	dobj	O
.	.	punct	O

Cancer	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
secrete	VBP	ROOT	O
soluble	JJ	amod	O
factors	NNS	dobj	O
which	WDT	nsubj	O
can	MD	aux	O
induce	VB	acl:relcl	O
proliferation	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Bovine	JJ	amod	B-Organism
lactoferrin	NN	nsubjpass	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
multifunctional	JJ	amod	O
glycoprotein	NN	appos	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
strongly	RB	advmod	O
inhibit	VB	xcomp	O
development	NN	dobj	O
of	IN	case	O
azoxymethane	NN	nmod:npmod	B-Simple_chemical
(	-LRB-	punct	O
AOM	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
-	:	punct	O
induced	VBN	amod	O
rat	NN	compound	B-Organism
colon	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

When	WRB	advmod	O
genetic	JJ	amod	O
ablation	NN	nsubjpass	O
of	IN	case	O
1	CD	nummod	O
or	CC	cc	O
2	CD	conj	O
alleles	NNS	nmod	O
of	IN	case	O
fur	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
overexpression	NN	conj	O
of	IN	case	O
the	DT	det	O
PLAG1	NN	compound	B-Gene_or_gene_product
transgene	NN	nmod	O
were	VBD	auxpass	O
simultaneously	RB	advmod	O
achieved	VBN	advcl	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
delay	NN	nsubjpass	O
in	IN	case	O
tumorigenesis	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

One	CD	nsubj	O
of	IN	prep	O
the	DT	det	O
most	RBS	amod	O
fundamental	JJ	pobj	O
is	VBZ	ROOT	O
the	DT	det	O
ability	NN	attr	O
to	TO	aux	O
act	VB	acl	O
as	IN	case	O
essential	JJ	amod	O
growth	NN	compound	O
checkpoint	NN	nmod	O
that	WDT	nsubj	O
protects	VBZ	acl:relcl	O
cells	NNS	dobj	B-Cell
against	IN	case	O
cellular	JJ	amod	B-Cell
transformation	NN	nmod	O
.	.	punct	O

The	DT	det	O
region	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
LTR	NN	nmod	B-Cellular_component
identified	VBN	acl	O
here	RB	advmod	O
as	IN	mark	O
being	VBG	cop	O
important	JJ	advcl	O
in	IN	case	O
trans	JJ	amod	O
activation	NN	nmod	O
has	VBZ	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
critical	JJ	amod	O
determinant	NN	xcomp	O
of	IN	case	O
the	DT	det	O
leukemogenicity	NN	nmod	O
and	CC	cc	O
latency	NN	conj	O
of	IN	case	O
Moloney	NN	compound	B-Organism
murine	JJ	amod	I-Organism
leukemia	NN	compound	I-Organism
virus	NN	nmod	I-Organism
.	.	punct	O

Opinions	NNS	nsubjpass	O
on	IN	case	O
3	CD	nummod	O
areas	NNS	nmod	O
were	VBD	auxpass	O
sought	VBN	ROOT	O
:	:	punct	O
pulp	JJ	amod	B-Tissue
therapy	NN	dobj	O
for	IN	case	O
cariously	RB	advmod	O
involved	VBN	amod	O
primary	JJ	amod	O
teeth	NNS	nmod	B-Organ
;	:	punct	O
indirect	JJ	amod	O
pulp	JJ	amod	B-Tissue
treatment	NN	parataxis	O
(	-LRB-	punct	O
IPT	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
cariously	RB	advmod	O
involved	VBN	amod	O
immature	JJ	amod	O
permanent	JJ	amod	O
teeth	NNS	nmod	B-Organ
;	:	punct	O
and	CC	cc	O
innovative	JJ	amod	O
treatment	NN	compound	O
options	NNS	conj	O
including	VBG	case	O
pulpal	JJ	amod	B-Tissue
revascularization	NN	nmod	O
and	CC	cc	O
regeneration	NN	conj	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
may	MD	aux	O
provide	VB	ROOT	O
clinical	JJ	amod	O
benefits	NNS	dobj	O
to	TO	case	O
cancer	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
.	.	punct	O

Assays	NNS	nsubj	O
of	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	nmod	O
,	,	punct	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
binding	NN	compound	O
specificity	NN	conj	O
,	,	punct	O
and	CC	cc	O
antigenicity	NN	conj	O
indicated	VBD	ROOT	O
that	IN	mark	O
Stat3	NN	nsubjpass	B-Gene_or_gene_product
or	CC	cc	O
a	DT	det	O
closely	RB	advmod	O
related	JJ	amod	O
STAT	NN	compound	B-Gene_or_gene_product
family	NN	compound	O
member	NN	conj	O
was	VBD	auxpass	O
constitutively	RB	advmod	O
activated	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
Src	NN	compound	B-Gene_or_gene_product
oncoprotein	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
confirm	VBP	ROOT	O
a	DT	det	O
close	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
metabolic	JJ	amod	O
enzymes	NNS	nmod	O
and	CC	cc	O
indicate	VBP	conj	O
an	DT	det	O
alteration	NN	dobj	O
in	IN	case	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

Vimentin	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
preferentially	RB	advmod	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
with	IN	case	O
high	JJ	amod	O
GF	NN	nmod	O
(	-LRB-	punct	O
greater	JJR	advmod	O
than	IN	advmod	O
15	CD	nummod	O
%	NN	dep	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	nummod	I-Gene_or_gene_product
positive	JJ	nmod	O
by	IN	case	O
immunoperoxidase	NN	compound	B-Gene_or_gene_product
staining	NN	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
low	JJ	amod	O
ER	NN	compound	B-Gene_or_gene_product
levels	NNS	conj	O
(	-LRB-	punct	O
less	JJR	advmod	O
than	IN	advmod	O
60	CD	nummod	O
fmols	NNS	dep	O
/	:	punct	O
mg	NN	compound	O
protein	NN	dep	O
by	IN	case	O
a	DT	det	O
monoclonal	JJ	amod	O
enzyme	NN	compound	O
immunoassay	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

DNA	NN	compound	B-Cellular_component
microarray	NN	compound	O
analysis	NN	nsubjpass	O
and	CC	cc	O
small	JJ	amod	O
animal	NN	compound	O
PET	NN	compound	O
studies	NNS	conj	O
may	MD	aux	O
be	VB	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
complementary	JJ	amod	O
technologies	NNS	nmod	O
in	IN	case	O
drug	NN	compound	O
development	NN	nmod	O
.	.	punct	O

Genes	NNS	nsubj	O
most	RBS	advmod	O
significantly	RB	advmod	O
represented	VBN	ROOT	O
in	IN	case	O
this	DT	det	O
program	NN	nmod	O
are	VBP	cop	O
those	DT	nmod	O
with	IN	case	O
roles	NNS	nmod	O
in	IN	case	O
cell	NN	compound	B-Cell
growth	NN	dep	O
and	CC	cc	O
proliferation	NN	conj	O
>	NN	dep	O
protein	NN	compound	O
synthesis	NN	dep	O
>	NN	dep	O
gene	NN	compound	O
expression	NN	nmod	O
>	NN	dep	O
cell	NN	compound	B-Cell
death	NN	compound	O
>	NN	amod	O
cell	NN	compound	B-Cell
cycle	NN	dep	O
.	.	punct	O

After	IN	case	O
incubation	NN	nmod	O
for	IN	case	O
4	CD	nummod	O
days	NNS	nmod	O
,	,	punct	O
the	DT	det	O
medium	NN	nsubjpass	O
from	IN	prep	O
the	DT	det	O
coculture	NN	compound	O
system	NN	pobj	O
is	VBZ	auxpass	O
collected	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
drugs	NNS	nsubj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
exhibit	VBP	ROOT	O
severe	JJ	amod	O
side	JJ	amod	O
effects	NNS	dobj	O
and	CC	cc	O
are	VBP	cop	O
expensive	JJ	conj	O
.	.	punct	O

In	IN	case	O
spite	NN	dep	O
of	IN	case	O
uncertainties	NNS	nmod	O
regarding	VBG	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
of	IN	case	O
carcinogenesis	NN	nmod	O
,	,	punct	O
several	JJ	amod	O
vitamins	NNS	appos	B-Simple_chemical
such	JJ	case	O
as	IN	mwe	O
beta	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
carotene	NN	nmod	I-Simple_chemical
and	CC	cc	O
vitamins	NNS	compound	B-Simple_chemical
A	NN	conj	I-Simple_chemical
,	,	punct	O
C	NN	conj	B-Simple_chemical
,	,	punct	O
and	CC	cc	O
E	NN	conj	B-Simple_chemical
,	,	punct	O
which	WDT	nsubj	O
can	MD	aux	O
reduce	VB	acl:relcl	O
the	DT	det	O
risk	NN	dobj	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
,	,	punct	O
using	VBG	xcomp	O
animal	NN	dobj	O
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
models	NNS	conj	O
of	IN	case	O
carcinogenesis	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Insulin	NN	nsubj	B-Gene_or_gene_product
increases	VBZ	appos	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	dobj	O
and	CC	cc	O
secreted	VBN	amod	O
protein	NN	compound	O
levels	NNS	conj	O
in	IN	case	O
RPE	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
through	IN	case	O
enhanced	VBN	amod	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

Long	JJ	compound	O
-	HYPH	punct	O
term	NN	compound	O
carcinogen	NN	compound	O
exposure	NN	nsubj	O
exerts	VBZ	ROOT	O
continuous	JJ	amod	O
pressure	NN	dobj	O
on	IN	case	O
key	JJ	amod	O
mechanisms	NNS	nmod	O
that	WDT	nsubj	O
repair	VBP	acl:relcl	O
or	CC	cc	O
eliminate	VB	conj	O
carcinogen	NN	npadvmod	O
-	HYPH	punct	O
damaged	VBN	amod	O
cells	NNS	dobj	B-Cell
giving	VBG	acl	O
rise	NN	dobj	O
to	TO	case	O
selective	JJ	amod	O
failures	NNS	nmod	O
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	appos	O
that	IN	mark	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	dep	O
effects	NNS	nsubj	O
of	IN	case	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nmod	I-Gene_or_gene_product
may	MD	aux	O
be	VB	auxpass	O
be	VB	cop	O
due	JJ	case	O
to	TO	case	O
interference	NN	xcomp	O
with	IN	case	O
the	DT	dep	O
proliferation	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
HUVECs	NNS	nmod	B-Cell
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
inhibition	NN	conj	O
of	IN	case	O
collagenolysis	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
leading	VBG	advcl	O
to	TO	case	O
inhibition	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
angiogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
growth	NN	conj	O
.	.	punct	O

Caspase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
procaspase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
processing	NN	nmod	O
and	CC	cc	O
cisplatin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	conj	O
of	IN	case	O
MCF	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Telomere	RB	compound	B-Cellular_component
/	SYM	punct	O
telomerase	NN	compound	B-Gene_or_gene_product
interplay	NN	ROOT	O
in	IN	case	O
virus	NN	compound	O
-	HYPH	punct	O
driven	VBN	amod	O
and	CC	cc	O
virus	NN	nmod:npmod	O
-	HYPH	punct	O
independent	JJ	amod	O
lymphomagenesis	NN	nmod	O
:	:	punct	O
pathogenic	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
implications	NNS	dep	O
.	.	punct	O

This	DT	det	O
altered	JJ	amod	O
energy	NN	compound	O
dependency	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
as	IN	prep	O
the	DT	det	O
"	``	punct	O
Warburg	NNP	compound	O
effect	NN	pobj	O
"	''	punct	O
and	CC	cc	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	conj	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
reported	VBN	ROOT	O
recently	RB	advmod	O
that	IN	mark	O
the	DT	det	O
long	JJ	amod	B-Cellular_component
terminal	JJ	amod	I-Cellular_component
repeat	NN	nsubj	I-Cellular_component
(	-LRB-	punct	O
LTR	NN	appos	B-Cellular_component
)	-RRB-	punct	O
of	IN	case	O
Moloney	NN	compound	B-Organism
murine	JJ	amod	I-Organism
leukemia	NN	compound	I-Organism
virus	NN	nmod	I-Organism
encodes	VBZ	ccomp	O
a	DT	det	O
trans	JJ	amod	O
activator	NN	dobj	O
which	WDT	nsubj	O
induces	VBZ	acl:relcl	O
transcription	NN	dobj	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
class	NN	compound	B-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
major	JJ	amod	I-Gene_or_gene_product
histocompatibility	NN	compound	I-Gene_or_gene_product
complex	NN	compound	I-Gene_or_gene_product
genes	NNS	nmod	O
and	CC	cc	O
certain	JJ	amod	O
cytokine	NN	compound	B-Gene_or_gene_product
genes	NNS	conj	O
.	.	punct	O

Metastatic	JJ	amod	B-Cancer
lesions	NNS	nsubjpass	I-Cancer
were	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O

Cell	NNP	compound	B-Cell
-	HYPH	punct	O
matrix	NN	compound	B-Cellular_component
adhesion	NN	compound	O
assay	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	dobj	O
the	DT	det	O
adhesive	JJ	amod	O
ability	NN	intj	O
of	IN	case	O
CNE1	NN	compound	B-Cell
-	:	punct	I-Cell
GL	NN	nmod	I-Cell
with	IN	case	O
the	DT	det	O
matrix	NN	nmod	B-Cellular_component
(	-LRB-	punct	O
mean	NN	amod	O
A	NN	compound	O
value	NN	dep	O
:	:	punct	O
1	CD	dep	O
.	.	punct	O
2508	CD	meta	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
0711	CD	nsubj	O
)	-RRB-	punct	O
was	VBD	cop	O
higher	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
CNE1	NN	compound	B-Cell
cell	NN	nmod	I-Cell
(	-LRB-	punct	O
mean	NN	amod	O
A	NN	compound	O
value	NN	dep	O
:	:	punct	O
0	CD	dep	O
.	.	punct	O
9519	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
068	CD	dep	O
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
001	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Deleted	VBN	ROOT	B-Gene_or_gene_product
in	IN	case	I-Gene_or_gene_product
split	JJ	amod	I-Gene_or_gene_product
hand	NN	nmod	I-Gene_or_gene_product
/	SYM	punct	I-Gene_or_gene_product
split	VBD	amod	I-Gene_or_gene_product
foot	NN	nsubj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Dss1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
gene	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
a	DT	det	O
heterogeneous	JJ	amod	O
limb	NN	compound	B-Organism_subdivision
developmental	JJ	amod	O
disorder	NN	nmod	O
called	VBN	acl	O
split	JJ	amod	O
hand	NN	dobj	B-Organism_subdivision
/	SYM	punct	O
split	VBD	amod	O
foot	NN	compound	B-Organism_subdivision
malformation	NN	nmod	O
.	.	punct	O

Immunoblotting	NN	amod	O
and	CC	cc	O
immunostaining	JJ	conj	O
studies	NNS	nsubj	O
demonstrated	VBD	ROOT	O
an	DT	det	O
upregulation	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
mostly	RB	advmod	O
along	IN	case	O
the	DT	det	O
endothelium	NN	compound	B-Tissue
lining	JJ	compound	O
peritoneal	JJ	amod	B-Multi-tissue_structure
blood	NN	compound	I-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
in	IN	case	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
PD	NN	compound	O
patients	NNS	nmod	B-Organism
.	.	punct	O

Radiation	NN	compound	O
retinopathy	NN	nsubj	O
is	VBZ	cop	O
treatable	JJ	ROOT	O
with	IN	case	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
vascular	JJ	amod	I-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
bevacizumab	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
Avastin	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
collection	NN	nsubj	O
of	IN	prep	O
reviews	NNS	pobj	O
at	IN	prep	O
the	DT	det	O
front	NN	amod	O
-	HYPH	punct	O
edge	NN	pobj	O
of	IN	prep	O
scientific	JJ	amod	O
knowledge	NN	pobj	O
focuses	VBZ	ROOT	O
on	IN	case	O
host	NN	compound	B-Cell
-	HYPH	punct	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
interactions	NNS	nmod	O
,	,	punct	O
the	DT	det	O
disastrous	JJ	amod	O
consequences	NNS	nsubj	O
they	PRP	nsubj	O
can	MD	aux	O
produce	VB	relcl	O
and	CC	cc	O
approaches	VBZ	conj	O
the	DT	det	O
ways	NNS	dobj	O
to	TO	aux	O
break	VB	acl	O
up	RP	prt	O
these	DT	det	O
cellular	JJ	amod	B-Cell
conspiracies	NNS	dobj	O
,	,	punct	O
to	TO	aux	O
leave	VB	parataxis	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
unattended	VBD	conj	O
and	CC	cc	O
vulnerable	JJ	conj	O
.	.	punct	O

Invasion	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
melanoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
BLM	NN	appos	B-Cell
,	,	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
attenuated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
PAI	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
monoclonal	JJ	amod	O
antibody	NN	compound	O
MAI	NNP	nmod	O
-	:	punct	O
12	CD	nummod	O
.	.	punct	O

The	DT	det	O
INK4	NN	compound	B-Gene_or_gene_product
family	NN	nsubj	O
of	IN	case	O
proteins	NNS	nmod	O
negatively	RB	advmod	O
regulates	VBZ	ROOT	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
progression	NN	dobj	O
at	IN	case	O
the	DT	det	O
G	NN	compound	O
(	-LRB-	punct	O
1	CD	dep	O
)	-RRB-	punct	O
-	:	punct	O
S	NN	compound	O
transition	NN	nmod	O
by	IN	mark	O
inhibiting	VBG	advcl	O
cyclin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
dependent	JJ	amod	I-Gene_or_gene_product
kinases	NNS	dobj	I-Gene_or_gene_product
.	.	punct	O

Experiments	NNS	nsubj	O
using	VBG	acl	O
the	DT	det	O
tsA	NN	compound	B-Gene_or_gene_product
58	CD	nummod	I-Gene_or_gene_product
allele	NN	dobj	O
of	IN	case	O
the	DT	det	O
SV	NNP	compound	B-Organism
40	CD	compound	I-Organism
-	HYPH	punct	O
A	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
SV	NN	compound	B-Organism
40	CD	nummod	I-Organism
large	JJ	amod	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
antigen	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
strictly	RB	advmod	O
required	VBN	ccomp	O
both	CC	cc:preconj	O
for	IN	case	O
immortalization	NN	nmod	O
and	CC	cc	O
induction	NN	compound	O
anchorage	VBP	compound	O
independence	NN	conj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Four	CD	nummod	O
weeks	NNS	npadvmod	O
later	RB	advmod	O
,	,	punct	O
islet	NN	dep	B-Multi-tissue_structure
gene	NN	compound	O
analysis	NN	nsubjpass	O
and	CC	cc	O
pancreas	NN	compound	B-Organ
immunochemistry	NN	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
knock	NN	compound	O
-	HYPH	punct	O
out	RP	intj	O
mice	NNS	nsubjpass	B-Organism
of	IN	case	O
homeobox	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
by	IN	case	O
targeted	VBN	amod	O
disruption	NN	nmod	O
have	VBP	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
examine	VB	xcomp	O
their	PRP$	nmod:poss	O
hematological	JJ	amod	O
effect	NN	dobj	O
.	.	punct	O

Further	JJ	amod	O
analysis	NN	nsubj	O
reveals	VBZ	ROOT	O
that	IN	mark	O
although	IN	mark	O
LMP1	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
TRADD	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
promotes	VBZ	advcl	O
cell	NN	compound	B-Cell
growth	NN	dobj	O
,	,	punct	O
it	PRP	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
prevent	VB	ccomp	O
the	DT	det	O
eventual	JJ	amod	O
onset	NN	dobj	O
of	IN	case	O
senescence	NN	nmod	O
and	CC	cc	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
p16	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
Ink4a	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
method	NN	nsubj	O
of	IN	mark	O
assessing	VBG	acl	O
vascular	JJ	amod	B-Tissue
endothelial	JJ	amod	I-Tissue
function	NN	dobj	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
is	VBZ	cop	O
via	IN	case	O
the	DT	det	O
quantification	NN	ROOT	O
of	IN	case	O
circulating	VBG	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
CEC	NN	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

(	-LRB-	punct	O
2	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
elucidate	VB	advcl	O
a	DT	det	O
mechanism	NN	dobj	O
for	IN	case	O
cancer	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
induced	VBN	amod	O
osteoclastogenesis	NN	nmod	O
,	,	punct	O
cells	NNS	conj	B-Cell
from	IN	case	O
a	DT	det	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
line	NN	nmod	O
,	,	punct	O
MDA	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	appos	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
,	,	punct	O
were	VBD	auxpass	O
directly	RB	advmod	O
co	NN	advmod	O
-	HYPH	punct	O
cultured	VBN	ROOT	O
with	IN	case	O
ST2	NN	nmod	B-Cell
,	,	punct	O
MC3T3	NN	compound	B-Cell
-	HYPH	punct	I-Cell
E1	NN	conj	I-Cell
,	,	punct	O
or	CC	cc	O
with	IN	case	O
primary	JJ	amod	O
mouse	NN	compound	B-Organism
calvarial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

[	-LRB-	ROOT	O
Autologous	JJ	amod	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
stem	NN	compound	I-Cell
cell	NN	intj	I-Cell
or	CC	cc	O
peripheral	JJ	amod	B-Cell
blood	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
progenitor	NN	compound	I-Cell
cell	NN	compound	I-Cell
therapy	NN	conj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
peripheral	JJ	amod	O
limb	NN	compound	B-Organism_subdivision
ischaemia	NN	nmod	O
]	-RRB-	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
apoptosis	NN	nsubjpass	O
caused	VBN	acl	O
by	IN	case	O
elevated	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
Fas	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
chemoprevention	NN	nmod	O
by	IN	case	O
lactoferrin	NN	nmod	B-Gene_or_gene_product
of	IN	case	O
colon	NN	compound	B-Organ
carcinogenesis	NN	nmod	O
.	.	punct	O

BAG	NNP	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
regulates	VBZ	ROOT	O
cellular	JJ	amod	B-Cell
growth	NN	dobj	O
,	,	punct	O
differentiation	NN	conj	O
and	CC	cc	O
survival	NN	conj	O
through	IN	case	O
interactions	NNS	nmod	O
with	IN	case	O
diverse	JJ	amod	O
proteins	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
vitamin	NN	compound	B-Gene_or_gene_product
D	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VDR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	appos	O
of	IN	case	O
keratinocyte	NN	nmod	B-Cell
growth	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
associations	NNS	nmod	O
among	IN	case	O
studied	VBN	amod	O
proteins	NNS	nmod	O
revealed	VBD	ROOT	O
positive	JJ	amod	O
correlation	NN	dobj	O
between	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
xL	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
Bax	NN	conj	B-Gene_or_gene_product
in	IN	case	O
primary	JJ	amod	O
tumors	NNS	nmod	B-Cancer
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
03	CD	dep	O
,	,	punct	O
r	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
307	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Cytokines	NNS	nsubj	B-Gene_or_gene_product
and	CC	cc	O
growth	NN	compound	B-Gene_or_gene_product
factors	NNS	conj	I-Gene_or_gene_product
induce	VBP	ROOT	O
tyrosine	NN	compound	B-Amino_acid
phosphorylation	NN	dobj	O
of	IN	case	O
signal	NN	compound	B-Gene_or_gene_product
transducers	NNS	nmod	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
activators	NNS	compound	I-Gene_or_gene_product
of	IN	amod	I-Gene_or_gene_product
transcription	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
STATs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
that	WDT	nsubj	O
directly	RB	advmod	O
activate	VBP	acl:relcl	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

The	DT	det	O
higher	JJR	amod	O
mortality	NN	compound	O
rate	NN	ROOT	O
in	IN	case	O
the	DT	det	O
folate	JJ	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
deficient	JJ	amod	O
group	NN	nmod	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
other	JJ	amod	O
two	CD	nummod	O
groups	NNS	nmod	O
(	-LRB-	punct	O
25	CD	nummod	O
%	NN	dep	O
versus	CC	cc	O
6	CD	conj	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
and	CC	cc	O
5	CD	conj	O
.	.	punct	O
6	CD	nummod	O
%	NN	nsubj	O
,	,	punct	O
P	NN	compound	O
<	-LRB-	appos	O
0	CD	nummod	O
.	.	punct	O
02	CD	appos	O
)	-RRB-	punct	O
partially	RB	advmod	O
accounted	VBD	ROOT	O
for	IN	case	O
the	DT	det	O
low	JJ	amod	O
incidence	NN	nmod	O
of	IN	case	O
high	JJ	amod	B-Pathological_formation
-	HYPH	punct	I-Pathological_formation
grade	NN	compound	I-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
in	IN	case	O
this	DT	det	O
group	NN	nmod	O
.	.	punct	O

Hyperforin	NN	ROOT	B-Simple_chemical
(	-LRB-	punct	O
Hyp	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
polyphenol	NN	compound	B-Simple_chemical
-	HYPH	punct	O
derivative	NN	appos	O
of	IN	prep	O
St	NN	pobj	B-Organism
.	.	punct	I-Organism

Collectively	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
furin	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
PLAG1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
salivary	JJ	amod	B-Multi-tissue_structure
gland	NN	compound	I-Multi-tissue_structure
tumorigenesis	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
selective	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
activation	NN	nmod	O
by	IN	case	O
NBD	NN	compound	B-Simple_chemical
peptide	NN	nmod	I-Simple_chemical
may	MD	aux	O
provide	VB	ccomp	O
an	DT	det	O
effective	JJ	amod	O
approach	NN	dobj	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
highly	RB	advmod	O
metastatic	JJ	amod	O
OSCC	NN	nmod	B-Cancer
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
serum	NN	compound	B-Organism_substance
VEGF	NN	compound	B-Gene_or_gene_product
level	NN	compound	O
(	-LRB-	punct	O
s	NNS	compound	O
-	:	punct	O
VEGF	NN	dobj	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
RCC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Vitamins	NNS	nsubj	B-Simple_chemical
regulate	VBP	ROOT	O
gene	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
induce	VBP	conj	O
differentiation	NN	dobj	O
and	CC	cc	O
growth	NN	compound	O
inhibition	NN	conj	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

TNF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
also	RB	advmod	O
an	DT	det	O
essential	JJ	amod	O
component	NN	ROOT	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
required	VBN	conj	O
for	IN	case	O
hematopoiesis	NN	nmod	O
,	,	punct	O
for	IN	case	O
protection	NN	nmod	O
from	IN	case	O
bacterial	JJ	amod	O
infection	NN	nmod	O
and	CC	cc	O
for	IN	case	O
immune	JJ	amod	B-Cell
cell	NN	nmod:npmod	I-Cell
-	HYPH	punct	O
mediated	VBN	amod	O
cytotoxicity	NN	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
neither	CC	cc:preconj	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
binding	NN	compound	O
region	NN	nsubj	O
nor	CC	cc	O
the	DT	det	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
homology	NN	compound	O
region	NN	conj	O
of	IN	case	O
T	NN	compound	B-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
prevent	VB	xcomp	O
cell	NN	compound	B-Cell
death	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
damaging	NN	amod	O
agent	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
maximum	NN	amod	O
tolerated	JJ	amod	O
dose	NN	nsubjpass	O
of	IN	case	O
galectin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3C	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
was	VBD	auxpass	O
determined	VBN	dep	O
to	TO	mark	O
be	VB	cop	O
>	NN	advmod	O
125	CD	nummod	O
mg	NN	compound	O
/	:	punct	O
kg	NN	xcomp	O
without	IN	case	O
overt	JJ	amod	O
adverse	JJ	amod	O
effects	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
mechanism	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubjpass	O
)	-RRB-	punct	O
by	IN	case	O
which	WDT	nmod	O
ciprofloxacin	NN	nsubj	B-Simple_chemical
elicits	VBZ	acl:relcl	O
its	PRP$	nmod:poss	O
biological	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
bladder	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
is	VBZ	auxpass	O
not	RB	neg	O
well	RB	advmod	O
documented	VBN	ROOT	O
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	ROOT	O
:	:	punct	O
An	DT	det	O
Affymetrix	NNP	compound	O
expression	NN	compound	O
microarray	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	dep	O
to	TO	mark	O
compare	VB	xcomp	O
gene	NN	compound	O
expression	NN	compound	O
profiles	NNS	dobj	O
between	IN	case	O
six	CD	nummod	O
pairs	NNS	nmod	O
of	IN	case	O
TFs	NN	nmod	B-Cell
and	CC	cc	O
normal	JJ	amod	O
fibroblasts	NNS	conj	B-Cell
from	IN	case	O
esophageal	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
ESCC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Concordance	NN	nsubjpass	O
in	IN	prep	O
topo	IN	pobj	B-Gene_or_gene_product
I	PRP	compound	I-Gene_or_gene_product
staining	VBG	nmod	O
between	IN	case	O
primary	JJ	amod	B-Cancer
and	CC	cc	O
lymph	NN	conj	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
33	CD	compound	O
of	IN	advmod	O
42	CD	nummod	O
cases	NNS	nmod	O
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	acl:relcl	O
.	.	punct	O
029	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
As	IN	prep	O
of	IN	prep	O
November	NNP	pobj	O
30	CD	nummod	O
,	,	punct	O
1994	CD	nummod	O
,	,	punct	O
the	DT	det	O
median	JJ	amod	O
follow	NN	compound	O
-	HYPH	punct	O
up	RP	cc	O
period	NN	nsubj	O
was	VBD	dep	O
12	CD	nummod	O
years	NNS	attr	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
TSP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	ROOT	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	xcomp	O
by	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	nmod	O
,	,	punct	O
p53	NN	appos	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	conj	O
by	IN	agent	O
oncogenes	NNS	pobj	O
such	JJ	amod	O
as	IN	prep	O
Myc	NNP	pobj	B-Gene_or_gene_product
and	CC	cc	O
Ras	NN	conj	B-Gene_or_gene_product
.	.	punct	O

NIH3T3	NN	compound	B-Cell
transfectant	NN	nsubj	I-Cell
containing	VBG	acl	O
human	JJ	amod	B-Organism
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	dobj	O
shows	VBZ	ROOT	O
enhanced	VBN	amod	O
metastatic	JJ	amod	O
activity	NN	dobj	O
after	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
or	CC	cc	O
co	NN	compound	O
-	HYPH	punct	O
culture	NN	conj	O
with	IN	case	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
VEGFR2	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
regulation	NN	nsubj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
function	NN	nmod	O
is	VBZ	cop	O
dependent	JJ	ccomp	O
on	IN	case	O
different	JJ	amod	O
but	CC	cc	O
specific	JJ	conj	O
Rab	NNP	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	dep	O
GTP	NN	compound	B-Simple_chemical
hydrolysis	NN	compound	O
activity	NN	nmod	O
required	VBN	acl	O
for	IN	case	O
endosomal	JJ	amod	B-Cellular_component
trafficking	NN	nmod	O
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
this	DT	det	O
observation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
generated	VBD	ROOT	O
the	DT	det	O
first	JJ	amod	O
transgenic	JJ	amod	O
mouse	NN	compound	B-Organism
model	NN	dobj	O
with	IN	case	O
a	DT	det	O
targeted	VBN	amod	O
overexpression	NN	nmod	O
of	IN	case	O
Tsg101	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
developing	VBG	amod	O
mammary	JJ	amod	B-Organ
gland	NN	nmod	I-Organ
to	TO	mark	O
test	VB	advcl	O
whether	IN	mark	O
exogenous	JJ	amod	O
Tsg101	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
capable	JJ	ccomp	O
of	IN	mark	O
initiating	VBG	advcl	O
tumorigenesis	NN	dobj	O
.	.	punct	O

Tumors	NNS	ROOT	B-Cancer
of	IN	case	O
the	DT	det	O
retinal	JJ	amod	B-Tissue
pigment	NN	amod	I-Tissue
epithelium	NN	compound	I-Tissue
metastasize	NN	nmod	O
to	TO	case	O
inguinal	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
spleen	NN	conj	B-Organ
in	IN	case	O
tyrosinase	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
SV40	NN	compound	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
transgenic	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
further	RB	advmod	O
estimated	VBD	ROOT	O
the	DT	det	O
threshold	NN	dobj	O
of	IN	case	O
APC	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
level	NN	nmod	O
that	WDT	nsubj	O
forms	VBZ	acl:relcl	O
one	CD	nummod	O
polyp	RB	dobj	B-Pathological_formation
per	IN	case	O
mouse	NN	nmod	B-Organism
as	IN	case	O
approximately	RB	advmod	O
15	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
the	DT	det	O
wild	JJ	amod	O
type	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
purpose	NN	nsubj	O
was	VBD	ROOT	O
to	TO	mark	O
examine	VB	xcomp	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cancer
cancers	NNS	dobj	I-Cancer
for	IN	case	O
inactivation	NN	nmod	O
of	IN	case	O
two	CD	nummod	O
candidate	NN	compound	O
metastasis	NN	compound	O
suppressor	NN	compound	O
genes	NNS	nmod	O
,	,	punct	O
nm23	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
H1	NN	appos	I-Gene_or_gene_product
and	CC	cc	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	conj	I-Gene_or_gene_product
,	,	punct	O
either	CC	cc:preconj	O
by	IN	case	O
mutation	NN	nmod	O
or	CC	cc	O
by	IN	case	O
loss	NN	conj	O
of	IN	case	O
gene	NN	compound	O
transcription	NN	nmod	O
.	.	punct	O

Media	NNS	nsubj	O
supplemented	VBD	ROOT	O
with	IN	prep	O
and	CC	cc	O
without	IN	conj	O
10	CD	nummod	O
%	NN	compound	O
Oxygent	NNP	nsubjpass	B-Simple_chemical
were	VBD	auxpass	O
compared	VBN	conj	O
in	IN	prep	O
all	DT	det	O
assessments	NNS	pobj	O
.	.	punct	O

Prolonged	JJ	amod	O
silencing	NN	nsubj	O
of	IN	case	O
both	DT	det	O
MCTs	NNS	nmod	B-Gene_or_gene_product
reduced	VBD	ROOT	O
viability	NN	dobj	O
by	IN	case	O
75	CD	nummod	O
%	NN	nmod	O
individually	RB	advmod	O
and	CC	cc	O
92	CD	nummod	O
%	NN	conj	O
in	IN	case	O
combination	NN	nmod	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
both	CC	cc:preconj	O
phenotypic	JJ	intj	O
and	CC	cc	O
flow	NN	compound	O
cytometric	JJ	amod	O
analyses	NNS	nmod	O
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	ROOT	O
:	:	punct	O
Both	CC	cc:preconj	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nsubjpass	I-Multi-tissue_structure
and	CC	cc	O
peripheral	JJ	amod	B-Organism_substance
blood	NN	compound	I-Organism_substance
samples	NNS	conj	I-Organism_substance
from	IN	case	O
810	CD	nummod	O
gastric	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
were	VBD	auxpass	O
collected	VBN	dep	O
at	IN	case	O
the	DT	det	O
Central	NNP	compound	O
Hospital	NNP	nmod	O
,	,	punct	O
National	NNP	compound	O
Cancer	NNP	compound	O
Center	NNP	appos	O
(	-LRB-	punct	O
Tokyo	NNP	appos	O
,	,	punct	O
Japan	NNP	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
FBS	NN	conj	B-Organism_substance
,	,	punct	O
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
enhanced	VBN	ROOT	O
upon	IN	case	O
addition	NN	nmod	O
of	IN	case	O
CHX	NN	nmod	B-Simple_chemical
or	CC	cc	O
Act	NNP	compound	B-Simple_chemical
D	NN	conj	I-Simple_chemical
.	.	punct	O

L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxyribose	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dR	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
thymidine	NN	compound	B-Simple_chemical
phosphorylase	NN	compound	I-Simple_chemical
inhibitor	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
TPI	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
can	MD	aux	O
reverse	VB	ROOT	O
these	DT	det	O
effects	NNS	dobj	O
.	.	punct	O

To	TO	mark	O
identify	VB	advcl	O
the	DT	det	O
underlying	VBG	amod	O
mechanism	NN	dobj	O
involved	VBN	acl	O
in	IN	case	O
such	JJ	amod	O
growth	NN	compound	O
-	HYPH	punct	O
factor	NN	nmod:npmod	O
/	:	punct	O
serum	NN	nmod:npmod	B-Organism_substance
independent	JJ	amod	O
growth	NN	nmod	O
of	IN	case	O
Galpha	NNP	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
QL	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
NIH3T3	NN	nmod	B-Cell
,	,	punct	O
we	PRP	nsubj	O
carried	VBD	ROOT	O
out	RP	prt	O
a	DT	det	O
two	CD	nummod	O
-	HYPH	punct	O
dimensional	JJ	amod	O
differential	JJ	amod	O
proteome	NN	compound	O
analysis	NN	dobj	O
of	IN	case	O
Galpha	NNP	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
QL	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
cells	NNS	conj	B-Cell
expressing	VBG	acl	O
vector	NN	compound	O
control	NN	dobj	O
.	.	punct	O

As	IN	case	O
with	IN	case	O
duplication	NN	nmod	O
of	IN	case	O
the	DT	det	O
entire	JJ	amod	O
TK	NN	nmod	O
/	:	punct	O
CAIN	NN	compound	O
region	NN	conj	O
(	-LRB-	punct	O
exons	NNS	dep	O
18	CD	nummod	O
-	SYM	punct	O
26	CD	nummod	O
)	-RRB-	punct	O
in	IN	case	O
A	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
172	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
duplication	NN	nsubjpass	O
of	IN	case	O
exons	NNS	nmod	O
18	CD	nummod	O
-	SYM	punct	O
25	CD	dep	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
specific	JJ	amod	O
genomic	JJ	amod	O
rearrangement	NN	nmod	O
between	IN	case	O
flanking	JJ	amod	O
introns	NNS	nmod	O
.	.	punct	O

Statistical	JJ	amod	O
analysis	NN	nsubjpass	O
is	VBZ	auxpass	O
performed	VBN	ROOT	O
and	CC	cc	O
P	NN	compound	O
<	ADD	conj	O
0	CD	nummod	O
.	.	punct	O
05	CD	nsubj	O
considered	VBN	ROOT	O
significant	JJ	xcomp	O
.	.	punct	O

Nineteen	NNP	nsubj	O
(	-LRB-	punct	O
79	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
putative	JJ	amod	O
NK	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	nsubj	I-Cancer
expressed	VBD	ROOT	O
perforin	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
all	DT	det	O
24	CD	nummod	O
cases	NNS	nsubj	O
expressed	VBD	conj	O
granzyme	NN	compound	B-Gene_or_gene_product
B9	NN	dobj	I-Gene_or_gene_product
and	CC	cc	O
TIA1	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
proapoptotic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
HDACi	NN	nmod	O
was	VBD	auxpass	O
robustly	RB	advmod	O
enhanced	VBN	ccomp	O
by	IN	case	O
E1A	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
multiple	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
normal	JJ	amod	O
cells	NNS	conj	B-Cell
.	.	punct	O

Histological	JJ	amod	O
examination	NN	nsubj	O
revealed	VBD	ROOT	O
cystic	JJ	amod	O
or	CC	cc	O
angiomatoid	NN	conj	O
spaces	NNS	dobj	O
of	IN	case	O
various	JJ	amod	O
sizes	NNS	nmod	O
lined	VBN	acl	O
by	IN	case	O
cuboidal	JJ	nmod	O
,	,	punct	O
low	JJ	amod	O
-	HYPH	punct	O
columnar	NN	conj	O
,	,	punct	O
or	CC	cc	O
flattened	VBN	amod	O
epithelioid	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
with	IN	case	O
vacuolated	VBN	amod	B-Organism_substance
cytoplasm	NN	nmod	I-Organism_substance
and	CC	cc	O
round	RB	conj	O
to	TO	case	O
oval	JJ	compound	O
nuclei	NNS	nmod	B-Cellular_component
.	.	punct	O

Although	IN	mark	O
both	CC	det	O
hypomorphic	JJ	amod	O
heterozygotes	NNS	nsubj	O
developed	VBD	advcl	O
intestinal	JJ	amod	B-Pathological_formation
polyps	NN	dobj	I-Pathological_formation
,	,	punct	O
tumor	NN	compound	B-Cancer
multiplicities	NNS	nsubj	O
were	VBD	cop	O
much	RB	advmod	O
lower	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
Apc	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
Delta716	JJ	amod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
mice	NNS	nmod	O
,	,	punct	O
heterozygotes	NNS	xcomp	O
of	IN	case	O
an	DT	det	O
Apc	NN	compound	B-Gene_or_gene_product
null	JJ	amod	O
allele	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
retroviral	JJ	amod	O
-	HYPH	punct	O
mediated	VBN	amod	O
gene	NN	compound	O
delivery	NN	dobj	O
to	TO	mark	O
effect	VB	advcl	O
sustained	JJ	amod	O
autocrine	JJ	compound	O
expression	NN	dobj	O
of	IN	case	O
TIMP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
murine	JJ	amod	B-Organism
neuroblastoma	NN	nmod	B-Cell
and	CC	cc	O
melanoma	NN	compound	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	conj	I-Cell
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
further	RB	advmod	O
examine	VB	advcl	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
TIMPs	NN	nmod	B-Gene_or_gene_product
to	TO	mark	O
inhibit	VB	acl	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubj	O
occurred	VBD	ROOT	O
in	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
pre	JJ	advmod	B-Pathological_formation
-	HYPH	punct	I-Pathological_formation
malignant	JJ	amod	I-Pathological_formation
tumor	NN	compound	I-Pathological_formation
formation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
enhanced	VBN	conj	O
in	IN	case	O
TSP	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	intj	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Since	IN	mark	O
both	DT	det	O
cell	NN	compound	B-Cell
lines	NNS	nsubj	I-Cell
remained	VBD	advcl	O
non	JJ	amod	O
-	HYPH	punct	O
tumorigenic	JJ	dobj	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
,	,	punct	O
these	DT	det	O
properties	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
they	PRP	nsubj	O
attained	VBD	ccomp	O
a	DT	det	O
premalignant	JJ	amod	O
phenotype	NN	dobj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
metastatic	JJ	amod	O
tumors	NNS	nsubjpass	B-Cancer
in	IN	case	O
mouse	NN	compound	B-Organism
lung	NN	nmod	B-Organ
were	VBD	auxpass	O
markedly	RB	advmod	O
decreased	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
and	CC	cc	O
acute	JJ	amod	O
lung	NN	compound	B-Organ
injury	NN	conj	O
induced	VBN	acl	O
by	IN	case	O
B16F10	NN	compound	B-Cancer
melanoma	NN	compound	I-Cancer
metastasis	NN	nmod	O
was	VBD	auxpass	O
diminished	VBN	conj	O
by	IN	case	O
systemic	JJ	amod	O
rk	IN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
treatment	NN	nmod	O
.	.	punct	O

Depletion	NN	nsubj	O
of	IN	case	O
Rab7a	NN	nmod	B-Gene_or_gene_product
decreased	VBD	ROOT	O
VEGFR2	NN	compound	B-Gene_or_gene_product
Y1175	NN	compound	O
phosphorylation	NN	dobj	O
but	CC	cc	O
increased	VBN	amod	O
p42	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
44	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
pERK1	NN	appos	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
2	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
MAPK	NN	compound	B-Gene_or_gene_product
phosphorylation	NN	conj	O
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
rate	NN	nsubj	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
transport	NN	nmod	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
pp60src	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
transforming	VBG	amod	O
protein	NN	appos	O
of	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod	I-Organism
.	.	punct	O

Clinical	JJ	amod	O
results	NNS	nsubjpass	O
induced	VBN	acl	O
by	IN	case	O
autologous	JJ	amod	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
or	CC	cc	O
angiogenic	JJ	amod	O
growth	NN	compound	O
/	:	punct	O
differentiation	NN	compound	O
factors	NNS	conj	O
in	IN	case	O
end	NN	compound	O
-	HYPH	punct	O
stage	NN	compound	O
patients	NNS	nmod	B-Organism
with	IN	case	O
PAD	NN	nmod	O
are	VBP	auxpass	O
summarized	VBN	ROOT	O
.	.	punct	O

Mechanisms	NNS	ROOT	O
responsible	JJ	amod	O
for	IN	prep	O
hyperinvasiveness	NN	pobj	O
and	CC	cc	O
resistance	NN	conj	O
to	TO	prep	O
anti	VB	npadvmod	O
-	HYPH	punct	O
invasive	JJ	amod	O
action	NN	pobj	O
of	IN	case	O
TGFbeta	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Increased	VBN	amod	O
MP	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
potential	NN	nmod	O
of	IN	case	O
many	JJ	amod	O
cancers	NNS	nmod	B-Cancer
,	,	punct	O
including	VBG	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
3	CD	nummod	O
-	HYPH	punct	O
year	NN	compound	O
disease	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
survival	NN	nsubjpass	O
(	-LRB-	punct	O
DFS	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
overall	JJ	amod	O
survival	NN	conj	O
(	-LRB-	punct	O
OS	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
tumors	NNS	nmod	B-Cancer
expressing	VBG	acl	O
different	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
COUP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NN	nmod	I-Gene_or_gene_product
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
Kaplan	NNP	compound	O
-	HYPH	punct	O
Meier	NNP	amod	O
method	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	nsubjpass	O
&	CC	cc	O
#	$	advmod	O
38	CD	conj	O
;	:	punct	O
OBJECTIVE	NN	appos	O
:	:	punct	O
It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
proved	VBN	ROOT	O
that	IN	mark	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	compound	I-Organism
(	-LRB-	punct	O
EBV	NN	appos	B-Organism
)	-RRB-	punct	O
latent	JJ	amod	B-Gene_or_gene_product
membrane	NN	compound	I-Gene_or_gene_product
protein	NN	nsubj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
EBV	NN	compound	B-Organism
-	:	punct	O
LMP1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
can	MD	aux	O
induce	VB	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	intj	I-Gene_or_gene_product
(	-LRB-	punct	O
MMP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
further	RB	advmod	O
establish	VBP	ROOT	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
PECAM	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
in	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nsubj	I-Gene_or_gene_product
may	MD	aux	O
stimulate	VB	ccomp	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
motility	NN	dobj	O
by	IN	mark	O
promoting	VBG	advcl	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
filopodia	NN	nmod	B-Cellular_component
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Although	IN	mark	O
many	JJ	amod	O
children	NNS	nsubj	B-Organism
with	IN	case	O
CHD	NN	nmod	O
develop	VBP	advcl	O
pulmonary	JJ	amod	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
disease	NN	dobj	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
unclear	JJ	dep	O
why	WRB	advmod	O
this	DT	det	O
complication	NN	nsubj	O
is	VBZ	cop	O
reversible	JJ	ccomp	O
after	IN	prep	O
complete	JJ	amod	O
repair	NN	pobj	O
in	IN	prep	O
some	DT	det	O
cases	NNS	pobj	O
but	CC	cc	O
irreversible	JJ	conj	O
in	IN	case	O
others	NNS	nmod	O
.	.	punct	O

The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
organ	NN	compound	B-Organ
vascularization	NN	nmod	O
and	CC	cc	O
lipoplex	JJ	compound	B-Simple_chemical
-	HYPH	punct	O
serum	NN	nmod:npmod	B-Organism_substance
initial	JJ	amod	O
contact	NN	conj	O
in	IN	case	O
intravenous	JJ	amod	B-Immaterial_anatomical_entity
murine	JJ	amod	B-Organism
lipofection	NN	nmod	O
.	.	punct	O

These	DT	det	O
functions	NNS	nsubj	O
include	VBP	ROOT	O
the	DT	det	O
first	JJ	amod	O
stages	NNS	dobj	O
of	IN	prep	O
sprouting	NN	pcomp	O
in	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
migration	NN	conj	O
following	VBG	case	O
wounding	NN	nmod	O
,	,	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	conj	O
.	.	punct	O

Intracerebral	JJ	amod	O
grafting	NN	ROOT	O
of	IN	case	O
cultured	VBN	amod	O
autologous	JJ	amod	O
skin	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
into	IN	case	O
the	DT	det	O
rat	NN	compound	B-Organism
striatum	NN	nmod	B-Multi-tissue_structure
:	:	punct	O
an	DT	det	O
assessment	NN	appos	O
of	IN	prep	O
graft	NN	compound	B-Tissue
size	NN	pobj	O
and	CC	cc	O
ultrastructure	NN	conj	O
.	.	punct	O

Nerve	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
NGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
to	TO	mark	O
support	VB	xcomp	O
survival	NN	dobj	O
and	CC	cc	O
differentiation	NN	conj	O
of	IN	case	O
neuroblastoma	NN	compound	B-Cell
(	-LRB-	punct	I-Cell
NB	NN	compound	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
TrkA	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	O
.	.	punct	O

p53	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
PCNA	NN	conj	B-Gene_or_gene_product
status	NN	dep	O
do	VBP	aux	O
not	RB	neg	O
appear	VB	ROOT	O
to	TO	mark	O
influence	VB	xcomp	O
topo	IN	compound	B-Gene_or_gene_product
I	NN	nummod	I-Gene_or_gene_product
expression	NN	dobj	O
,	,	punct	O
and	CC	cc	O
topo	NN	nsubj	B-Gene_or_gene_product
I	PRP	nsubj	I-Gene_or_gene_product
has	VBZ	conj	O
no	DT	neg	O
apparent	JJ	amod	O
association	NN	dobj	O
with	IN	case	O
the	DT	det	O
acquisition	NN	nmod	O
of	IN	case	O
a	DT	det	O
metastatic	JJ	amod	O
phenotype	NN	nmod	O
.	.	punct	O

Through	IN	case	O
this	DT	det	O
domain	NN	nmod	O
,	,	punct	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nsubj	I-Gene_or_gene_product
physically	RB	advmod	O
interacts	VBZ	ROOT	O
with	IN	case	O
Smad3	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
mediator	NN	appos	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
signaling	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
suppressing	VBG	advcl	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
Smad3	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
insulin	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
was	VBD	auxpass	O
examined	VBN	dep	O
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	compound	O
studies	NNS	nmod	O
of	IN	case	O
rat	NN	compound	B-Organism
retinal	JJ	amod	B-Multi-tissue_structure
VEGF	NN	compound	B-Gene_or_gene_product
transcripts	NNS	nmod	O
.	.	punct	O

The	DT	det	O
alternative	JJ	amod	O
splicing	NN	nsubj	O
of	IN	case	O
Brn	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3a	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
produces	VBZ	ROOT	O
two	CD	nummod	O
molecular	JJ	amod	O
forms	NNS	dobj	O
:	:	punct	O
a	DT	det	O
longer	RBR	amod	O
,	,	punct	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
transactivating	NN	compound	O
form	NN	dep	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
shorter	JJR	amod	O
inactive	JJ	amod	O
form	NN	conj	O
,	,	punct	O
lacking	VBG	acl	O
84	CD	nummod	O
AA	NN	dobj	O
in	IN	prep	O
the	DT	det	O
aminoterminus	NN	pobj	O
.	.	punct	O

This	DT	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
largest	JJS	amod	O
study	NN	attr	O
to	TO	prep	O
date	NN	pobj	O
evaluating	VBG	acl	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
inhibitors	NNS	dobj	O
as	IN	case	O
adjunctive	JJ	amod	O
therapy	NN	nmod	O
in	IN	case	O
haemophilia	NN	nmod	O
and	CC	cc	O
suggests	VBZ	conj	O
that	IN	mark	O
these	DT	det	O
agents	NNS	nsubj	O
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
adjunctive	JJ	amod	O
therapy	NN	ccomp	O
in	IN	case	O
the	DT	det	O
management	NN	nmod	O
of	IN	case	O
haemophilia	NN	nmod	O
.	.	punct	O

After	IN	case	O
removal	NN	nmod	O
of	IN	case	O
fibroblasts	NNS	nmod	B-Cell
by	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
G	NN	nmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
418	CD	nummod	I-Simple_chemical
,	,	punct	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
exhibited	VBD	ROOT	O
increased	VBN	amod	O
metastatic	JJ	amod	O
ability	NN	dobj	O
and	CC	cc	O
human	JJ	amod	B-Organism
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	compound	O
mRNA	NN	conj	O
,	,	punct	O
suggesting	VBG	advcl	O
an	DT	det	O
intimate	JJ	amod	O
interaction	NN	dobj	O
between	IN	case	O
H	NN	compound	B-Cell
-	HYPH	punct	I-Cell
3	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
fibroblasts	NNS	conj	B-Cell
influencing	VBG	acl	O
the	DT	det	O
function	NN	dobj	O
of	IN	case	O
transfected	VBN	amod	O
human	JJ	amod	B-Organism
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	nmod	O
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
pathway	NN	dobj	O
in	IN	case	O
Hoxa9	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
Meis1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
leukemogenesis	NN	conj	O
,	,	punct	O
retroviral	JJ	amod	B-Organism
insertional	JJ	amod	O
mutagenesis	NN	nsubjpass	O
was	VBD	auxpass	O
applied	VBN	ROOT	O
using	VBG	xcomp	O
retrovirus	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
gene	NN	compound	O
transfer	NN	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
supplementation	NN	nsubj	O
with	IN	case	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Carnitine	NNP	nmod	I-Simple_chemical
as	IN	case	O
an	DT	det	O
adjuvant	JJ	amod	O
therapy	NN	nmod	O
may	MD	aux	O
be	VB	aux	O
promising	JJ	ROOT	O
in	IN	prep	O
alleviating	VBG	pcomp	O
the	DT	det	O
systemic	JJ	amod	O
side	NN	compound	O
-	HYPH	punct	O
effects	NNS	dobj	O
of	IN	prep	O
chemotherapeutics	NNS	pobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
transient	JJ	amod	O
transfection	NN	compound	O
studies	NNS	nsubj	O
with	IN	case	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
indicated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
activated	VBN	amod	O
Galpha	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
readily	RB	advmod	O
increased	VBD	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
SET	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
by	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

Matrix	NN	compound	O
metalloproteinase	NN	compound	O
/	:	punct	O
tissue	NN	compound	O
inhibitors	NNS	nsubj	O
of	IN	case	O
matrix	NN	compound	O
metalloproteinase	NN	compound	O
phenotype	NN	nmod	O
identifies	VBZ	ROOT	O
poor	JJ	amod	O
prognosis	NN	compound	O
colorectal	JJ	compound	B-Cancer
cancers	NNS	dobj	I-Cancer
.	.	punct	O

No	DT	neg	O
correlations	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
between	IN	case	O
glycolytic	JJ	amod	O
rates	NNS	nmod	O
and	CC	cc	O
pAkt	JJ	compound	B-Gene_or_gene_product
levels	NNS	conj	O
.	.	punct	O

This	DT	det	O
protein	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
protein	NN	compound	O
kinase	NN	xcomp	O
that	WDT	nsubj	O
phosphorylates	VBZ	acl:relcl	O
on	IN	case	O
tyrosine	NN	compound	O
residues	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
current	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
loss	NN	nsubj	O
of	IN	case	O
function	NN	nmod	O
by	IN	case	O
either	CC	cc:preconj	O
targeted	VBN	amod	O
allele	NN	compound	O
deletion	NN	nmod	O
or	CC	cc	O
use	NN	conj	O
of	IN	case	O
a	DT	det	O
soluble	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
Dll4	NN	compound	B-Gene_or_gene_product
extracellular	JJ	amod	B-Immaterial_anatomical_entity
domain	NN	nmod	O
leads	VBZ	ccomp	O
to	TO	case	O
inhibition	NN	nmod	O
of	IN	case	O
Notch	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
increased	VBN	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
proliferation	NN	nmod	O
but	CC	cc	O
defective	JJ	amod	O
maturation	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
used	VBD	ROOT	O
neutralizing	VBG	amod	O
Abs	NNS	dobj	O
to	TO	mark	O
show	VB	xcomp	O
that	IN	mark	O
the	DT	det	O
IFN	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
protein	NN	nsubj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
10	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
monokine	NN	conj	O
-	,	punct	O
induced	VBN	acl	O
by	IN	case	O
IFN	NN	compound	O
-	HYPH	punct	O
gamma	NN	compound	O
chemokines	NNS	nmod	O
are	VBP	cop	O
pivotal	JJ	ccomp	O
in	IN	mark	O
inducing	VBG	advcl	O
these	DT	det	O
effects	NNS	dobj	O
.	.	punct	O

In	IN	case	O
all	DT	det	O
patients	NNS	nmod	B-Organism
,	,	punct	O
a	DT	det	O
major	JJ	amod	O
and	CC	cc	O
consistent	JJ	conj	O
induction	NN	nsubjpass	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
target	NN	compound	O
genes	NNS	nmod	O
was	VBD	auxpass	O
seen	VBN	ROOT	O
.	.	punct	O

Hence	RB	advmod	O
,	,	punct	O
the	DT	det	O
down	JJ	amod	O
-	HYPH	punct	O
regulation	NN	nsubj	O
of	IN	case	O
p21WAF1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
together	RB	advmod	O
with	IN	case	O
the	DT	det	O
alterations	NNS	nmod	O
in	IN	case	O
Bax	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
cdk2	NN	conj	B-Gene_or_gene_product
as	IN	mark	O
observed	VBN	acl	O
in	IN	case	O
our	PRP$	nmod:poss	O
studies	NNS	nmod	O
,	,	punct	O
may	MD	aux	O
define	VB	ROOT	O
a	DT	det	O
novel	JJ	amod	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
ciprofloxacin	NN	nsubj	B-Simple_chemical
inhibits	VBZ	acl:relcl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
.	.	punct	O

5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Azacytidine	NNP	nsubj	I-Simple_chemical
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
DNA	NN	compound	B-Cellular_component
methylation	NN	compound	O
inhibitor	NN	appos	O
,	,	punct	O
induced	VBD	ROOT	O
growth	NN	dobj	O
of	IN	prep	O
large	JJ	amod	O
colonies	NNS	pobj	O
in	IN	case	O
soft	JJ	amod	O
agar	NN	compound	O
cultures	NNS	nmod	O
of	IN	case	O
Rat	NN	compound	B-Cell
6	CD	nummod	I-Cell
or	CC	cc	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	conj	I-Gene_or_gene_product
cells	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
Tsg101	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
highly	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
invasive	JJ	amod	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
proposed	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
switch	NN	nsubj	O
from	IN	case	O
tumor	NN	compound	B-Cancer
suppressor	NN	nmod	O
to	IN	case	O
oncogene	NN	nmod	O
reflects	VBZ	ccomp	O
genetic	JJ	amod	O
or	CC	cc	O
epigenetic	JJ	conj	O
alterations	NNS	dobj	O
in	IN	case	O
signaling	NN	compound	O
pathways	NNS	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
alter	VBP	acl:relcl	O
the	DT	det	O
readout	NN	dobj	O
from	IN	case	O
the	DT	det	O
TGFbeta1	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
.	.	punct	O

sVAP	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	cop	O
also	RB	advmod	O
an	DT	det	O
independent	JJ	amod	O
predictive	JJ	amod	O
marker	NN	ROOT	O
for	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
topo	NN	compound	B-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
sex	NN	conj	O
,	,	punct	O
Dukes	NNP	nmod:poss	O
'	POS	case	O
stage	NN	conj	O
,	,	punct	O
differentiation	NN	compound	O
grade	NN	conj	O
,	,	punct	O
survival	NN	compound	O
status	NN	conj	O
,	,	punct	O
p53	NN	compound	B-Gene_or_gene_product
status	NN	conj	O
,	,	punct	O
and	CC	cc	O
PCNA	NN	compound	B-Gene_or_gene_product
status	NN	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
MCT	NN	nsubj	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
was	VBD	cop	O
the	DT	det	O
predominantly	RB	advmod	O
expressed	VBN	amod	O
isoform	NN	ROOT	O
in	IN	case	O
normal	JJ	amod	O
brain	NN	nmod	B-Organ
.	.	punct	O

Gliomas	NNS	nsubj	B-Cancer
are	VBP	ROOT	O
the	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
primary	JJ	amod	O
tumours	NNS	attr	B-Cancer
of	IN	prep	O
the	DT	det	O
central	JJ	amod	B-Anatomical_system
nervous	JJ	amod	I-Anatomical_system
system	NN	pobj	I-Anatomical_system
,	,	punct	O
with	IN	prep	O
nearly	RB	advmod	O
15	CD	nummod	O
,	,	punct	O
000	CD	nsubj	O
diagnosed	VBN	pcomp	O
annually	RB	advmod	O
in	IN	prep	O
the	DT	det	O
United	NNP	compound	O
States	NNP	pobj	O
and	CC	cc	O
a	DT	det	O
lethality	NN	conj	O
approaching	VBG	acl	O
80	CD	nummod	O
%	NN	dobj	O
within	IN	case	O
the	DT	det	O
first	JJ	amod	O
year	NN	nmod	O
of	IN	case	O
glioblastoma	NN	compound	B-Cancer
diagnosis	NN	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
under	IN	case	O
normal	JJ	amod	O
conditions	NNS	compound	O
muscle	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
express	VBP	ROOT	O
only	RB	advmod	O
a	DT	det	O
approximately	RB	advmod	O
5	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
-	HYPH	punct	O
kb	NN	compound	O
type	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
HK	NN	compound	I-Gene_or_gene_product
RNA	NN	compound	O
transcript	NN	dobj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
this	DT	det	O
therapeutic	JJ	amod	O
approach	NN	nsubj	O
markedly	RB	advmod	O
promotes	VBZ	ccomp	O
angiogenesis	NN	dobj	O
and	CC	cc	O
granulation	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
formation	NN	conj	O
in	IN	case	O
comparison	NN	nmod	O
with	IN	case	O
other	JJ	amod	O
conditions	NNS	nmod	O
14	CD	nummod	O
days	NNS	dobj	O
after	IN	case	O
wounding	NN	pobj	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Bovine	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nsubjpass	I-Cell
(	-LRB-	punct	O
ECs	NNS	appos	B-Cell
)	-RRB-	punct	O
were	VBD	auxpass	O
cultured	VBN	ROOT	O
.	.	punct	O

All	DT	det	O
data	NNS	nsubjpass	O
are	VBP	auxpass	O
reported	VBN	ROOT	O
as	IN	case	O
means	NNS	compound	O
+	CC	cc	O
/	SYM	punct	O
-	HYPH	punct	O
SEM	NNP	nmod	O
.	.	punct	O

The	DT	det	O
dynamic	JJ	amod	O
uptake	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
analogue	NN	nmod	O
[	-LRB-	punct	B-Simple_chemical
18F	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
FDG	NN	nsubjpass	I-Simple_chemical
was	VBD	auxpass	O
measured	VBN	ROOT	O
in	IN	case	O
diseased	JJ	amod	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
upper	JJ	amod	B-Organism_subdivision
arm	NN	compound	I-Organism_subdivision
skeletal	JJ	amod	B-Tissue
muscle	NN	conj	I-Tissue
in	IN	case	O
both	DT	det	O
metabolic	JJ	amod	O
states	NNS	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
anabolic	JJ	amod	O
properties	NNS	nsubjpass	O
of	IN	case	O
insulin	NN	nmod	B-Gene_or_gene_product
have	VBP	aux	O
been	VBN	auxpass	O
suggested	VBN	appos	O
for	IN	case	O
use	NN	nmod	O
to	TO	mark	O
reverse	VB	acl	O
malnutrition	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nsubj	I-Gene_or_gene_product
recruits	VBZ	appos	O
mononuclear	JJ	amod	B-Cell
phagocytes	NNS	dobj	I-Cell
which	WDT	nsubj	O
regulate	VBP	acl:relcl	O
processes	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
angiogenesis	NN	nmod	O
and	CC	cc	O
metastases	NNS	conj	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
that	DT	mark	O
hCAP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
18	CD	dep	I-Gene_or_gene_product
/	SYM	punct	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
significantly	RB	advmod	O
overexpressed	VBN	acl:relcl	O
in	IN	case	O
ovarian	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
and	CC	cc	O
suggest	VBP	conj	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nsubj	I-Gene_or_gene_product
may	MD	aux	O
contribute	VB	conj	O
to	TO	case	O
ovarian	JJ	amod	B-Organ
tumorigenesis	NN	nmod	O
through	IN	case	O
direct	JJ	amod	O
stimulation	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
initiation	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
recruitment	NN	conj	O
of	IN	case	O
immune	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
filopodia	NN	compound	B-Cellular_component
formation	NN	nsubjpass	O
,	,	punct	O
a	DT	det	O
feature	NN	appos	O
of	IN	case	O
motile	JJ	compound	O
cells	NNS	nmod	B-Cell
,	,	punct	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
in	IN	case	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
null	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
human	JJ	amod	B-Organism
endothelial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
treated	VBN	acl	O
with	IN	case	O
either	DT	cc:preconj	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PECAM	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
antibody	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
siRNA	NN	conj	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
cultured	VBN	acl	O
in	IN	case	O
the	DT	det	O
conditioned	JJ	amod	O
media	NNS	nmod	O
.	.	punct	O

